Benign leiomyoma with endometriosis

CD2_LEIOMYOMA_ENDOMETRIOSIS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions N14_ENDOMETRIOSIS	20882
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints CD2_BENIGN_LEIOMYOMA_UTERI	6504
6. Filter based on genotype QC (FinnGen only)	6504

Control definitions (FinnGen only)

Control conditions: not N14_ENDOMETRIOSIS

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF10

NAME	CD2_LEIOMYOMA_ENDOMETRIOSIS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!N14_ENDOMETRIOSIS
SEX	2
INCLUDE	CD2_BENIGN_LEIOMYOMA_UTERI
PRE_CONDITIONS
CONDITIONS	N14_ENDOMETRIOSIS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign leiomyoma with endometriosis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign leiomyoma with endometriosis

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6504	6504	-
Unadjusted period prevalence (%)	2.22	2.22	-
Median age at first event (years)	43.97	43.97	-

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5903: Matched controls
59030

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

62532

ICD-8 Finland

Other diseases of uterus, Endometriosis retro-cervicalis sive retrouterina

+∞

323.0

539

6173A

ICD-9 Finland

Endometriosis of pelvic peritoneum[ENDOMETRIOSIS SEROSAE PELVIS]

+∞

323.0

343

2180A

ICD-9 Finland

Uterine leiomyoma, Submucous leiomyoma of uterus

7.4

323.0

1619

2882

6171A

ICD-9 Finland

Endometriosis of ovary

+∞

323.0

660

6173B

ICD-9 Finland

Endometriosis of pelvic peritoneum[ENDOMETRIOSIS RETROUTERINA]

+∞

323.0

490

D25.1

ICD-10 Finland

Intramural leiomyoma of uterus

6.5

323.0

1345

2571

N80.0

ICD-10 Finland

Endometriosis of uterus

1220.6

323.0

1176

62530

ICD-8 Finland

Other diseases of uterus, Endometriosis ovarii

+∞

323.0

579

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

11843.6

323.0

999

N80.9

ICD-10 Finland

Endometriosis, unspecified

407.4

323.0

384

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

6.5

323.0

2014

4336

N80.1

ICD-10 Finland

Endometriosis of ovary

2685.6

323.0

1154

21899

ICD-8 Finland

Uterine fibroma

7.8

323.0

1224

1917

6170A

ICD-9 Finland

Endometriosis of uterus

+∞

323.0

514

62533

ICD-8 Finland

Other diseases of uterus, Adenomyosis uteri

+∞

317.6

302

N80.4

ICD-10 Finland

Endometriosis of rectovaginal septum and vagina

1650.0

316.2

305

JAL21

NOMESCO Finland

Laparoscopic excision or destruction of lesion of peritoneum

58.8

209.5

248

D25.0

ICD-10 Finland

Submucous leiomyoma of uterus

4.7

184.1

683

1598

LCD00

NOMESCO Finland

Hysterectomy

4.1

183.5

788

2126

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

4.5

173.6

680

1676

62531

ICD-8 Finland

Other diseases of uterus, Endometriosis serosae pelvis

+∞

167.5

160

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

2.3

166.6

4482

34234

8341

FHL

Colony removal or incineration

151.4

153.1

162

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

3.1

151.0

953

3456

D25.2

ICD-10 Finland

Subserosal leiomyoma of uterus

5.8

135.5

405

734

8306

FHL

Hysterectomy (related to abortion 8516, prolapse correction 8436)

4.1

132.6

568

1507

62538

ICD-8 Finland

Other diseases of uterus, Endometriosis alia

+∞

127.5

122

8201

FHL

Ovarian preservation exploration and related procedures, eg resection, enucleation or ovariolysis

7.9

124.0

297

395

1413

FHL

Laparoscopy and other therapeutic procedure

5.5

123.8

392

760

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

2.6

121.7

1041

4513

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.7

113.9

892

3661

LAF00

NOMESCO Finland

Unilateral salpingo-oophorectomy

8.7

109.2

245

293

N73.6

ICD-10 Finland

Female pelvic peritoneal adhesions

10.4

103.5

209

207

N80.8

ICD-10 Finland

Other endometriosis

+∞

101.3

LBF01

NOMESCO Finland

Laparoscopic perfusion of Fallopian tube

12.2

100.3

187

158

JAH01

NOMESCO Finland

Laparoscopy

3.7

99.2

464

1319

121

Kela drug reimbursment

Severe hypofunction of sexual glands

6.3

98.9

276

456

LAF01

NOMESCO Finland

Laparoscopic unilateral salpingo-oophorectomy

5.1

98.7

332

687

N80.5

ICD-10 Finland

Endometriosis of intestine

+∞

95.0

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.8

91.7

2247

14964

6178X

ICD-9 Finland

Endometriosis of other specified sites

+∞

86.7

LAC01

NOMESCO Finland

Laparoscopic excision of ovarian cyst

9.6

85.7

180

192

6146A

ICD-9 Finland

Inflammatory disease of ovary, Fallopian tube, pelvic cellular tissue and peritoneum, Pelvic peritoneal adhesions, female

7.1

83.4

213

311

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

6.7

81.2

216

334

B02AA02

ATC

tranexamic acid; systemic

2.0

80.0

1271

7188

8308

FHL

Hysterectomy and bilateral adnexal removal

4.6

79.7

293

665

8307

FHL

Hysterectomy and unilateral removal of adhesions

7.1

79.3

202

294

8305

FHL

Supravaginal amputation or resection

4.5

79.0

299

698

G03DC03

ATC

lynestrenol; oral

4.9

78.7

269

565

LAC21

NOMESCO Finland

Laparoscopic destruction of lesion of ovary

16.8

78.4

127

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

77.7

1471

8861

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

6.7

77.5

205

315

8204

FHL

Salpingo-oophorectomy

6.3

76.4

213

351

N97.9

ICD-10 Finland

Female infertility, unspecified

3.7

75.4

357

1021

N80.89

ICD-10 Finland

Endometriosis with other specified or multiple localization

727.2

73.3

N97.8

ICD-10 Finland

Female infertility of other origin

9.6

72.4

152

162

1410

FHL

Laparoscopy

3.7

70.5

331

939

LBE01

NOMESCO Finland

Laparoscopic salpingectomy

4.6

68.1

246

548

62539

ICD-8 Finland

Other diseases of uterus, Endometriosis NUD

+∞

65.7

LCB11

NOMESCO Finland

Laparoscopic myomectomy

17.7

65.0

103

H01CA02

ATC

nafarelin; nasal

4.4

63.8

240

557

N80.81

ICD-10 Finland

Endometriosis in sacrouteral ligament

+∞

63.6

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.6

62.8

484

1930

N80.2

ICD-10 Finland

Endometriosis of fallopian tube

+∞

62.6

LCB10

NOMESCO Finland

Myomectomy

12.1

61.9

115

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

61.3

2173

15594

61610

ICD-8 Finland

Diseases of parametrium and pelvic peritoneum (female), Pelvic peritoneal adhesions, female

5.3

58.9

188

366

G03FA01

ATC

norethisterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

0.5

57.8

481

9125

N99.4

ICD-10 Finland

Postprocedural pelvic peritoneal adhesions

7.3

57.3

142

199

8302

FHL

Tumor removal (e.g., enucleation) or polyp removal

7.5

56.8

138

188

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.0

55.1

843

4626

LBE20

NOMESCO Finland

Laparoscopic bilateral salpingectomy

6.5

55.0

148

233

G03GA01

ATC

chorionic gonadotrophin; parenteral

3.3

51.6

275

860

8351

FHL

Removal of pelvic floor brackets

8.1

51.5

119

150

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

3.3

50.2

269

845

LCD11

NOMESCO Finland

Laparoscopically assisted vaginal hysterectomy

4.2

49.4

195

474

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

47.8

2164

16196

L02AE03

ATC

goserelin; implant

7.8

47.3

111

144

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

2.6

46.9

367

1471

G03GA02

ATC

human menopausal gonadotrophin; parenteral

3.9

46.6

203

540

G03DA04

ATC

progesterone; systemic, rectal, vaginal

2.6

45.9

345

1352

L02AE02

ATC

leuprorelin; implant, parenteral

6.4

44.2

120

192

62800

ICD-8 Finland

Sterility, female, Sterilitas primaria

4.2

43.1

169

409

G03GA06

ATC

follitropin beta; parenteral

3.7

42.5

196

548

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.5

41.0

473

8230

8113

FHL

Fractional scraping

1.9

39.5

646

3605

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

38.9

1495

10660

G03XB02

ATC

ulipristal; oral (progesterone receptor modulators)

11.2

38.7

N80

ICD-10 Finland

Endometriosis

29.1

38.6

M01AE02

ATC

naproxen; oral, rectal

1.4

38.3

3270

27430

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

36.3

632

3597

LAA10

NOMESCO Finland

Percutaneous or transvaginal puncture and recovery of oocyte

4.4

34.7

128

293

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.1

34.4

410

2019

G03FB05

ATC

norethisterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

0.6

33.9

435

7387

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

0.6

33.3

576

9084

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

33.2

1282

9092

XLA10

NOMESCO Finland

2.0

33.1

448

2324

N94.6

ICD-10 Finland

Dysmenorrhoea, unspecified

5.4

32.7

101

191

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

2.2

32.7

339

1566

LCF01

NOMESCO Finland

Laparoscopic excision of lesion of parametrium

37.5

32.4

8343

FHL

Combined endometriosis surgery

318.7

31.9

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

31.6

2231

17824

A02BC05

ATC

esomeprazole; systemic

1.4

30.9

2414

19612

G03GA05

ATC

follitropin alfa; parenteral

3.5

30.6

150

442

6289A

ICD-9 Finland

Infertility, female, Of unspecified origin[STERILITAS ET INFERTILITAS MULIERIS NUD PRIM]

5.4

29.6

172

LCD97

NOMESCO Finland

Other laparoscopic hysterectomy

9.9

28.8

355

Kela drug reimbursment

Dienogest

293.3

28.8

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

1.9

28.7

455

2499

LCG31

NOMESCO Finland

Laparoscopic resection or transcision of sacrouterine ligaments

150.7

28.7

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

28.6

432

2332

L02AE01

ATC

buserelin; implant, nasal, parenteral

4.2

28.5

111

269

LEF13

NOMESCO Finland

Colpoperineoplasty and vaginal hysterectomy

0.2

28.5

1497

N02AX02

ATC

tramadol; systemic, rectal

1.4

28.3

2243

18173

LAD00

NOMESCO Finland

Partial excision of ovary

17.7

28.3

LCC10

NOMESCO Finland

Supravaginal hysterectomy

5.7

28.1

146

G03FA12

ATC

medroxyprogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

0.4

28.0

139

3185

N81.2

ICD-10 Finland

Incomplete uterovaginal prolapse

0.4

27.7

102

2626

N83.1

ICD-10 Finland

Corpus luteum cyst

4.2

27.5

107

259

LCD10

NOMESCO Finland

Vaginal hysterectomy

2.2

27.5

304

1448

G03DB08

ATC

dienogest; oral

+∞

27.1

LAC00

NOMESCO Finland

Excision of ovarian cyst

10.5

26.7

G03FB06

ATC

medroxyprogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

0.6

26.5

361

6066

6421

FHL

Appendicectomy

2.0

26.4

334

1684

G03AC03

ATC

levonorgestrel; systemic

0.6

26.2

386

6359

6202X

ICD-9 Finland

Noninflammatory disorders of ovary, Fallopian tube and broad ligament, Other and unspecified ovarian cyst

3.1

26.1

145

471

N70.1

ICD-10 Finland

Chronic salpingitis and oophoritis

3.7

25.4

115

319

LAC20

NOMESCO Finland

Destruction of lesion of ovary

19.1

25.2

LCB14

NOMESCO Finland

Laparoscopic myolysis

3.6

24.9

116

330

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

24.7

1522

11743

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

24.6

668

4321

A02BC02

ATC

pantoprazole; systemic

1.3

24.5

3738

33262

6200A

ICD-9 Finland

Noninflammatory disorders of ovary, Fallopian tube and broad ligament, Follicular cyst of ovary

4.5

24.3

195

61520

ICD-8 Finland

Other diseases of ovary and Fallopian tube, Cysta (cystis) follicularis ovarii (retentio)

3.0

24.1

140

469

J02AC01

ATC

fluconazole; systemic

1.3

24.0

2724

23155

N80.6

ICD-10 Finland

Endometriosis in cutaneous scar

+∞

24.0

N94.4

ICD-10 Finland

Primary dysmenorrhoea

5.1

23.2

147

A02BA02

ATC

ranitidine; systemic

1.4

22.9

1111

8180

N02BE01

ATC

paracetamol; systemic, rectal

1.4

22.8

5047

47375

LAD01

NOMESCO Finland

Laparoscopic partial excision of ovary

13.0

22.8

ZXE00

NOMESCO Finland

One hour or less

1.3

22.3

2147

17747

M01AH05

ATC

etoricoxib; oral

1.3

22.1

3321

29241

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

3.6

21.8

100

282

G03FA14

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

0.5

21.8

158

3183

LBE00

NOMESCO Finland

Salpingectomy

4.8

21.6

155

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

21.6

1006

7341

G03GB02

ATC

clomifene; oral

2.5

21.5

172

701

6288A

ICD-9 Finland

Infertility, female, Of other specified origin[STERILITAS ET INFERTILITAS MULIERIS ALIA PRIM]

12.3

21.3

P01AB01

ATC

metronidazole; oral, rectal

1.3

21.1

2392

20193

R2110

NOMESCO Finland

Giving the first information

1.7

21.1

428

2549

6262A

ICD-9 Finland

Disorders of menstruation and other abnormal bleeding from female genital tract, Excessive or frequent menstruation[HYPERMENORRHOEA]

2.1

21.0

235

1124

6175A

ICD-9 Finland

Endometriosis of intestine

+∞

20.8

LCA06

NOMESCO Finland

Biopsy of endometrium

1.5

20.7

914

6594

N83.0

ICD-10 Finland

Follicular cyst of ovary

3.1

20.5

114

373

LAE11

NOMESCO Finland

Unilateral laparoscopic oophorectomy

5.1

20.0

124

N95.0

ICD-10 Finland

Postmenopausal bleeding

0.6

19.7

309

5035

62400

ICD-8 Finland

Malposition of uterus, Retroversion and retroflexion

4.1

19.7

185

Z35.0

ICD-10 Finland

Supervision of pregnancy with history of infertility

2.9

19.6

124

440

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

19.6

2046

17017

JAL97

NOMESCO Finland

Other laparoscopic excision of lesion of peritoneum

16.4

19.6

62660

ICD-8 Finland

Disorders of menstruation, Intermenstrual bleeding

2.0

19.3

252

1286

1411

FHL

Laparoscopy and cyst puncture

6.0

19.3

N97.1

ICD-10 Finland

Female infertility of tubal origin

4.5

19.2

152

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.8

19.2

339

1931

G03GA04

ATC

urofollitropin; parenteral

4.3

19.0

168

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

0.8

18.6

1570

19028

8202

FHL

Oophorectomy

5.8

18.2

N06AA09

ATC

amitriptyline; systemic

1.5

18.2

614

4173

LA2AE

NOMESCO Finland

Ultrasound examination of ovarian cyst

3.5

18.2

245

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

18.0

325

1861

6172A

ICD-9 Finland

Endometriosis of Fallopian tube

+∞

17.7

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

2.2

17.7

192

908

8342

FHL

Cleavage and resection of sacrouterines

180.5

17.5

R01AD08

ATC

fluticasone; nasal

1.3

17.4

1549

12549

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.8

17.2

309

1769

J01DB01

ATC

cefalexin; oral

1.3

17.0

4518

42109

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

2.1

16.5

191

930

62620

ICD-8 Finland

Disorders of menstruation, Excessive

2.3

16.4

147

636

G03FB08

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

0.5

16.0

179

3178

UKC02

NOMESCO Finland

Cystoscopy

1.5

15.8

556

3813

LC2HE

NOMESCO Finland

Hystero-salpingography with ultrasound

1.8

15.8

280

1599

N80.80

ICD-10 Finland

Bladder endometriosis

+∞

15.6

62550

ICD-8 Finland

3.4

15.6

222

SPAT1153

SPAT

Removal of sutures

1.3

15.5

1703

14150

8349

FHL

Other measure in this category

160.4

15.5

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.7

15.4

377

5587

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

1.9

15.2

220

1172

N39.3

ICD-10 Finland

Stress incontinence

1.5

15.2

545

3753

K66.0

ICD-10 Finland

Peritoneal adhesions

4.2

15.1

133

M03BX02

ATC

tizanidine; oral

1.2

15.0

3459

31359

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

15.0

2588

22700

62699

ICD-8 Finland

Disorders of menstruation, Other

1.9

15.0

218

1164

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

4.3

14.9

125

H02AB06

ATC

prednisolone; systemic

1.2

14.9

2469

21553

R01AD09

ATC

mometasone; nasal

1.2

14.7

2458

21463

H01CC01

ATC

ganirelix; parenteral

2.7

14.7

367

UJF32

NOMESCO Finland

Coloscopy

1.3

14.5

1360

11043

LCA30

NOMESCO Finland

Transfer of oocyte or embryo to uterus in assisted fertilisation

5.2

14.2

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

14.1

344

2155

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

2.9

14.0

302

J01AA02

ATC

doxycycline; systemic

1.3

13.9

4497

42206

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

13.8

838

6369

M79.7

ICD-10 Finland

Fibromyalgia

1.8

13.8

220

1215

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

0.6

13.7

200

3317

62630

ICD-8 Finland

Disorders of menstruation, Painful

2.9

13.7

274

N93.8

ICD-10 Finland

Other specified abnormal uterine and vaginal bleeding

2.4

13.4

116

497

G44.2

ICD-10 Finland

Tension-type headache

1.4

13.4

732

5461

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

13.4

1849

15739

J01FA10

ATC

azithromycin; systemic

1.2

13.4

3179

28739

61521

ICD-8 Finland

Other diseases of ovary and Fallopian tube, Cysta (cystis) corporis lutei ovarii

3.3

13.3

196

M01AB05

ATC

diclofenac; systemic, rectal

1.2

13.1

3633

33350

J02AC02

ATC

itraconazole; systemic

1.3

13.1

1016

8019

G02BA03

ATC

plastic IUD with progestogen

0.7

13.1

336

4934

1350

FHL

Hysteroscopy

2.7

13.0

342

M54.5

ICD-10 Finland

Low back pain

1.3

12.9

1710

14469

N06AB04

ATC

citalopram; systemic

1.3

12.7

1170

9455

XF402

NOMESCO Finland

ECG with work load test

1.5

12.4

511

3617

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.7

12.4

271

1649

WX402

NOMESCO Finland

General anaesthesia

1.4

12.4

788

6028

M01AH01

ATC

celecoxib; oral (coxibs)

1.3

12.3

1034

8250

C07AB07

ATC

bisoprolol; oral

1.2

12.3

2334

20533

6289B

ICD-9 Finland

Infertility, female, Of unspecified origin[STERILITAS ET INFERTILITAS MULIERIS NUD SEC]

3.7

12.3

146

A02BC01

ATC

omeprazole; systemic

1.3

12.0

1436

11987

L02AB02

ATC

medroxyprogesterone; systemic (progestogens)

3.6

12.0

144

N03AX16

ATC

pregabalin; oral

1.3

11.8

1250

10278

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

11.7

3019

27345

TLW12

NOMESCO Finland

Insertion of frozen embryo

3.4

11.7

162

TLW10

NOMESCO Finland

Transfer of fresh embryo

3.3

11.7

178

W12

ICPC

Contraception intrauterine

0.5

11.7

112

2074

A03FA02

ATC

cisapride; oral, rectal

1.5

11.6

429

2971

A02BC03

ATC

lansoprazole; oral

1.2

11.6

1581

13392

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

11.5

1476

12413

6179X

ICD-9 Finland

Endometriosis, site unspecified

+∞

11.5

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

11.4

1137

9266

J01FA09

ATC

clarithromycin; systemic

1.2

11.4

1690

14444

M79.6

ICD-10 Finland

Pain in limb

1.2

11.4

1964

17064

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.7

11.4

241

1456

M01AX05

ATC

glucosamine; oral

1.3

11.3

1264

10460

C07AA05

ATC

propranolol; systemic

1.3

11.3

1025

8258

ULC02

NOMESCO Finland

Hysteroscopy

1.5

11.2

365

2460

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.4

11.2

620

4632

2200A

ICD-9 Finland

Benign neoplasm of ovary[NEOPLASMA BENIGNUM OVARII]

2.5

11.1

361

D25

ICD-10 Finland

Leiomyoma of uterus

2.6

11.1

308

M01AH02

ATC

rofecoxib; oral

1.3

11.1

732

5632

N06AX21

ATC

duloxetine; oral

1.4

11.1

564

4153

N92.4

ICD-10 Finland

Excessive bleeding in the premenopausal period

1.6

10.9

255

1583

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

10.8

971

7801

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

10.8

1320

11026

LAE10

NOMESCO Finland

Unilateral oophorectomy

4.2

10.7

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

10.6

839

6619

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

10.6

2563

22977

N06AX16

ATC

venlafaxine; oral

1.3

10.4

679

5204

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

10.4

1490

12668

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

10.3

602

4537

6266A

ICD-9 Finland

Disorders of menstruation and other abnormal bleeding from female genital tract, Metrorrhagia

1.6

10.3

266

1697

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

10.3

5034

48349

J01DA01

ATC

[U] cefalexin; systemic

1.2

10.3

3376

31120

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

10.2

2241

19886

LCA10

NOMESCO Finland

Curettage of body of uterus

1.8

10.2

183

1055

M01AX17

ATC

nimesulide; oral

1.2

10.2

1364

11506

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

10.2

1144

9454

N97.2

ICD-10 Finland

Female infertility of uterine origin

13.1

10.1

R51.80

ICD-10 Finland

Headache

1.3

10.1

703

5445

J01CA08

ATC

pivmecillinam; oral

1.2

10.1

2918

26557

O34.1

ICD-10 Finland

Maternal care for tumour of corpus uteri

4.1

10.1

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

10.1

1178

9778

6253A

ICD-9 Finland

Pain and other symptoms associated with female genital organs, Dysmenorrhoea

3.3

10.0

145

D01

ICPC

Abdominal pain/cramps general

1.4

10.0

505

3715

LEG10

NOMESCO Finland

Vaginal urethrocystopexy

1.7

10.0

190

1115

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

10.0

590

4458

M01AG01

ATC

mefenamic acid; oral

1.9

9.8

150

820

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.4

9.8

436

3137

R03AC02

ATC

salbutamol; inhalant

1.2

9.8

2811

25545

LAG01

NOMESCO Finland

Laparoscopic freeing of adhesions of ovary

10.6

9.8

ICD-9 Finland

3.8

9.7

107

J01MA01

ATC

ofloxacin; systemic

1.5

9.7

367

2554

SPAT1308

SPAT

Sexual health counselling

0.6

9.7

123

2110

K07.60

ICD-10 Finland

Snapping jaw

1.6

9.5

247

1577

LBE10

NOMESCO Finland

Bilateral salpingectomy

8.4

9.5

6288B

ICD-9 Finland

Infertility, female, Of other specified origin[STERILITAS ET INFERTILITAS MULIERIS ALIA SEC]

10.0

9.5

ZXD20

NOMESCO Finland

Day surgery

1.3

9.5

658

5093

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

9.5

653

5053

6282A

ICD-9 Finland

Infertility, female, Of tubal origin[STERIL ET INFERT EX ORIG TUBAE UTERINAE PRIM]

4.2

9.4

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

9.4

770

6101

62801

ICD-8 Finland

Sterility, female, Sterilitas secundaria

2.7

9.4

220

22099

ICD-8 Finland

Benign neoplasm of ovary, Other and unspecified

2.0

9.4

109

539

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.5

9.4

288

1918

6201A

ICD-9 Finland

Noninflammatory disorders of ovary, Fallopian tube and broad ligament, Corpus luteum cyst or haematoma

3.4

9.3

132

S18

ICPC

Laceration/cut

1.2

9.3

2091

18548

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

9.3

1205

10109

N03AX12

ATC

gabapentin; oral

1.3

9.3

774

6148

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

9.3

505

3761

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

9.3

453

3313

LBF00

NOMESCO Finland

Perfusion of Fallopian tube

4.2

9.2

N97.4

ICD-10 Finland

Female infertility associated with male factors

2.5

9.2

265

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

9.2

921

7492

8203

FHL

Salpingectomy

3.7

9.2

103

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

9.1

2325

20854

J01MA02

ATC

ciprofloxacin; systemic

1.2

9.1

1811

15875

Z2221

NOMESCO Finland

Medical doctor

1.2

9.1

1391

11878

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

9.0

539

4075

C05AA08

ATC

fluocortolone; rectal, topical

1.3

9.0

713

5629

N06AX11

ATC

mirtazapine; oral

1.2

9.0

1640

14257

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

1.6

8.9

200

1234

M02AA07

ATC

piroxicam; topical

1.2

8.9

2058

18287

6280A

ICD-9 Finland

Infertility, female, Associated with anovulation[STERILITAS ET INFERTILITAS ANOVULATORIA PRIM]

5.7

8.9

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.0

8.8

113

579

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

8.8

1195

10071

R06AE07

ATC

cetirizine; oral

1.2

8.8

2405

21681

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

8.7

326

2267

LA2JE

NOMESCO Finland

Follow-up of menstrual cycle with repeated measurement of ovarian cyst

4.4

8.7

SPAT1190

SPAT

Insertion or removal of intrauterine contraceptive device

0.5

8.7

1193

LCF96

NOMESCO Finland

Other excision of lesion of parametrium

50.0

8.7

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

0.7

8.7

219

3224

LDW96

NOMESCO Finland

Other operation on cervix uteri

4.8

8.6

N30.0

ICD-10 Finland

Acute cystitis

1.3

8.5

807

6514

LWW96

NOMESCO Finland

Other reoperation in gynaecological surgery

4.2

8.5

LCB97

NOMESCO Finland

Other laparoscopic excision of lesion of uterus

20.0

8.5

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

2.2

8.5

396

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

8.4

495

3736

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

8.4

815

6604

LAE21

NOMESCO Finland

Bilateral laparoscopic oophorectomy

4.2

8.4

6176A

ICD-9 Finland

Endometriosis in scar of skin

+∞

8.3

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

8.2

1795

15845

N73.9

ICD-10 Finland

Female pelvic inflammatory disease, unspecified

2.3

8.1

306

62650

ICD-8 Finland

Disorders of menstruation, Irregular

2.0

8.1

467

D27.91

ICD-10 Finland

Benign epithelial tumor of the ovary (ovary)

2.1

8.0

431

WX002

NOMESCO Finland

Sedation and analgesia

1.2

8.0

980

8156

J01FA06

ATC

roxithromycin; oral

1.2

8.0

2174

19542

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.6

7.9

203

1295

M25.5

ICD-10 Finland

Pain in joint

1.2

7.9

1499

13043

8219

FHL

Other measure in this category

4.7

7.9

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.4

7.9

422

3139

D06

ICPC

Abdominal pain localized other

1.4

7.8

385

2825

XF404

NOMESCO Finland

Ambulatory ECG

1.4

7.8

398

2937

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

2.5

7.7

236

LAE20

NOMESCO Finland

Bilateral oophorectomy

3.3

7.7

109

LAA31

NOMESCO Finland

Ovarioscopy

6.3

7.7

K30

ICD-10 Finland

Functional dyspepsia

1.3

7.7

534

4136

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

7.6

2084

18715

MAX99

NOMESCO Finland

Assistance to normal delivery

0.6

7.6

1554

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.4

7.6

314

2230

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.2

7.6

1542

13500

XKC03

NOMESCO Finland

Water cystometry

1.6

7.6

170

1049

G03FA17

ATC

drospirenone and estrogen; systemic

0.5

7.6

1059

Z30.0

ICD-10 Finland

General counselling and advice on contraception

0.5

7.6

1140

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

1.9

7.5

504

JHB00

NOMESCO Finland

Hemorrhoidectomy

1.7

7.5

158

961

G04BD08

ATC

solifenacin; oral

1.4

7.5

336

2422

21900

ICD-8 Finland

Other benign neoplasm of uterus, Papiloma, polyp

2.1

7.4

385

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

7.4

2028

18213

Z37.0

ICD-10 Finland

Single live birth

0.6

7.4

127

2019

M54.2

ICD-10 Finland

Cervicalgia

1.4

7.3

327

2355

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.2

7.3

1124

9581

6174A

ICD-9 Finland

Endometriosis of rectovaginal septum and vagina

+∞

7.3

G04BD12

ATC

mirabegron; oral

1.3

7.2

505

3913

G01AF04

ATC

miconazole; vaginal

1.4

7.2

316

2267

61620

ICD-8 Finland

Diseases of parametrium and pelvic peritoneum (female), Pelvic congestion, female

4.5

7.2

6561

FHL

Removal of fasteners and related measures

3.8

7.2

R05

ICD-10 Finland

Cough

1.2

7.2

959

8047

Z31.2

ICD-10 Finland

In vitrofertilization

3.4

7.2

LDC03

NOMESCO Finland

Conisation of cervix uteri using diathermy or laser

0.6

7.1

1441

L03

ICPC

Low back symptom/complaint

1.2

7.1

1236

10653

LWE00

NOMESCO Finland

Reoperation for deep haemorrhage in gynaecological surgery

3.1

7.1

116

R03DC03

ATC

montelukast; oral

1.2

7.1

813

6710

C08CA01

ATC

amlodipine; oral

1.2

7.1

1668

14772

R53

ICD-10 Finland

Malaise and fatigue

1.2

7.1

960

8070

A02BC04

ATC

rabeprazole; oral

1.4

7.1

409

3078

F20.9

ICD-10 Finland

Schizophrenia, unspecified

0.2

7.1

384

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

1.9

7.1

528

LAB01

NOMESCO Finland

Laparoscopic ovariotomy

12.0

7.1

R01AD01

ATC

beclometasone; nasal

1.3

7.1

767

6291

6210A

ICD-9 Finland

Disorders of uterus, not elsewhere classified, Polyp of corpus uteri

2.2

7.0

282

C09CA06

ATC

candesartan; oral

1.2

7.0

1067

9074

TLC02

NOMESCO Finland

Simple extraction of IUD

1.5

7.0

201

1322

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

7.0

375

2787

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

7.0

118

671

G04BD04

ATC

oxybutynin; oral, transdermal

1.4

7.0

295

2100

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

0.5

7.0

920

G01AF05

ATC

econazole; vaginal

1.3

7.0

527

4128

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.4

7.0

282

1994

1530

FHL

Urethrocystoscopy

2.2

7.0

296

WX110

NOMESCO Finland

Local anesthesy

1.2

7.0

3543

33308

N94.1

ICD-10 Finland

Dyspareunia

2.5

6.9

194

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

3.2

6.9

108

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

5.4

6.9

R00.2

ICD-10 Finland

Palpitations

1.4

6.9

353

2605

XKD03

NOMESCO Finland

Urethral pressure profilometry

1.7

6.8

141

853

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.2

6.8

2051

18521

R01AD12

ATC

fluticasone furoate; nasal

1.2

6.8

1452

12747

LAA06

NOMESCO Finland

Transvaginal puncture of ovarian cyst

2.8

6.8

149

R01AD05

ATC

budesonide; nasal

1.4

6.8

379

2839

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

6.8

593

4740

LAC11

NOMESCO Finland

Laparoscopic fenestration or marsupialisation of ovarian cyst

16.7

6.7

LCF97

NOMESCO Finland

Other laparoscopic excision of lesion of parametrium

16.7

6.7

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

6.7

590

4716

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.3

6.7

386

2908

R30.0

ICD-10 Finland

Dysuria

1.6

6.7

159

1001

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

5.9

6.6

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.3

6.6

558

4442

A06AC51

ATC

ispaghula, combinations; systemic

1.4

6.6

250

1750

Z3231

NOMESCO Finland

Registered nurse

1.2

6.6

1255

10907

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.2

6.5

970

8229

M01AC06

ATC

meloxicam; systemic, rectal

1.2

6.5

2046

18520

M79.1

ICD-10 Finland

Myalgia

1.3

6.5

632

5117

L01

ICPC

Neck symptom/complaint

1.3

6.5

690

5647

N05BA12

ATC

alprazolam; oral

1.3

6.5

514

4055

R06AX27

ATC

desloratadine; oral

1.2

6.5

1335

11678

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.3

6.5

509

4014

J01EA01

ATC

trimethoprim; systemic

1.2

6.4

1534

13585

N02CC03

ATC

zolmitriptan; nasal, oral

1.4

6.4

265

1883

M01AB01

ATC

indometacin; systemic, rectal

1.4

6.4

251

1767

M01AB55

ATC

diclofenac, combinations; oral

1.4

6.4

353

2640

A07AA02

ATC

nystatin; oral

1.4

6.4

317

2329

Z3226

NOMESCO Finland

Physiotherapist

1.2

6.4

871

7320

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

1.5

6.4

232

1605

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.3

6.4

464

3615

Z54.0

ICD-10 Finland

Convalescence following surgery

2.0

6.4

391

N03AX11

ATC

topiramate; oral

1.7

6.4

112

647

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

6.3

494

3892

B01AB05

ATC

enoxaparin; parenteral

1.2

6.3

1563

13877

N83.9

ICD-10 Finland

Noninflammatory disorder of ovary, fallopian tube and broad ligament, unspecified

3.3

6.3

R01AD11

ATC

triamcinolone; nasal

1.3

6.3

440

3412

Z2445

NOMESCO Finland

Psychologist

1.7

6.3

124

742

M01AH03

ATC

valdecoxib; oral

1.4

6.3

307

2250

SPAT1263

SPAT

Sampling

1.2

6.3

2123

19310

M54

ICD-10 Finland

Dorsalgia

1.3

6.3

505

3992

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

6.3

1122

9691

LCG30

NOMESCO Finland

Resection or transcision of sacrouterine ligaments

+∞

6.2

G03DC02

ATC

norethisterone; oral

1.2

6.2

815

6824

S01GX01

ATC

cromoglicic acid; ophthalmic

1.2

6.2

1036

8887

R52.9

ICD-10 Finland

Pain, unspecified

1.3

6.2

391

2987

R31

ICD-10 Finland

Unspecified haematuria

1.4

6.2

241

1696

JEA00

NOMESCO Finland

Appendectomy

1.4

6.2

249

1762

D27.99

ICD-10 Finland

Benign tumor of the ovary (ovary), unspecified histology

2.6

6.2

158

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.3

6.2

491

3877

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

0.2

6.2

337

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

0.4

6.2

610

LEB10

NOMESCO Finland

Excision of lesion of vagina

2.8

6.2

128

Z09.9

ICD-10 Finland

Follow-up examination after unspecified treatment for other conditions

2.2

6.1

262

Q50.10

ICD-10 Finland

A developmental cyst in the ovary

2.3

6.1

234

N02CC04

ATC

rizatriptan; oral

1.4

6.1

282

2049

LAG00

NOMESCO Finland

Freeing of adhesions of ovary

12.5

6.1

Z30.4

ICD-10 Finland

Surveillance of contraceptive drugs

0.4

6.0

695

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.3

6.0

445

3479

M54.4

ICD-10 Finland

Lumbago with sciatica

1.2

6.0

789

6610

XKD00

NOMESCO Finland

Uroflowmetry

1.5

6.0

214

1479

J01MA06

ATC

norfloxacin; oral

1.2

6.0

762

6360

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

436

2053

2.20

49.15

1.5

pmol/l

81.2

196.2

8.97

421

1997

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

806

5031

1.69

38.25

3.0

3.9

u/ml

43.2

66.6

2.04

779

4844

(3013707) Erythrocyte sedimentation rate by Westergren method

4855

43863

1.42

31.79

4.4

mm/h

12.1

13.3

8.36

4403

40527

(40768804) Tissue Pathology biopsy report

3021

25493

1.35

29.26

2.3

2.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

4324

39066

1.32

23.20

5.2

4.9

e6/l

3541.1

2600.2

0.32

468

(3037467) Urinalysis macro (dipstick) panel - Urine

4395

39863

1.32

22.53

5.0

4.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1037

13742

0.71

22.08

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1000

7366

1.42

21.40

4.8

4.6

33.9

33.6

0.38

657

4804

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5141

47839

1.36

21.17

4.9

4.6

pmol/l

14.9

0.07

4622

43602

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5665

53616

1.44

20.68

13.8

13.1

ml/min/173m2

78.8

78.5

0.36

4769

44097

(3023103) Potassium [Moles/volume] in Serum or Plasma

6107

58777

1.64

19.88

16.2

15.9

mmol/l

3.9

4.80

5936

57176

(3019550) Sodium [Moles/volume] in Serum or Plasma

6094

58630

1.63

19.76

16.0

15.8

mmol/l

139.7

0.65

5935

57149

(3013512) EKG study

2033

17034

1.28

17.86

4.0

3.8

—

(3019225) pH of Specimen

839

6191

1.41

17.53

3.9

4.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5719

54577

1.40

16.61

6.0

5.5

mu/l

2.2

2.0

0.23

5194

50078

(3002256) Pathology report gross observation

1009

7818

1.34

15.43

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

2139

18291

1.25

15.25

2.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1765

14773

1.27

15.09

4.1

3.7

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4826

45172

1.26

14.71

7.5

7.4

u/l

76.3

78.1

2.50

4446

42324

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

380

2.44

14.23

1.3

1.6

ug/l

2.0

4.2

1.39

258

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2424

21201

1.23

13.62

3.5

ng/l

25.5

80.7

1.40

1567

14088

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2983

26663

1.22

13.49

3.7

3.8

—

(3006504) Eosinophils/100 leukocytes in Blood

2969

26615

1.21

12.76

5.7

6.0

2.8

0.03

2713

24618

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2094

18152

1.23

12.55

2.4

u/l

56.9

58.1

0.32

1889

16527

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5855

56486

1.37

12.44

14.3

14.0

mg/l

20.2

21.5

2.15

4691

44589

(3019069) Monocytes/100 leukocytes in Blood

2978

26755

1.21

12.36

6.0

6.3

8.2

8.4

2.31

2748

24880

(42870588) Differential panel, method unspecified - Blood

2230

19484

1.22

12.31

5.5

5.8

—

(3003338) MCHC [Mass/volume]

4425

46960

0.82

11.93

18.5

g/l

330.3

0.13

4396

46659

(3002030) Lymphocytes/100 leukocytes in Blood

3031

27362

1.20

11.71

5.8

6.1

28.7

28.3

1.00

2780

25292

(40768797) Stomach Pathology biopsy report

1067

8648

1.28

11.47

1.2

—

(40761536) Microorganisms panel - Urine sediment

630

4765

1.36

11.13

4.8

4.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3871

35850

1.20

10.95

3.2

3.0

u/l

44.5

43.9

0.13

3527

33047

(3022096) Basophils/100 leukocytes in Blood

2863

25828

1.19

10.82

5.8

6.0

0.7

0.22

2620

23894

(3032080) INR in Blood by Coagulation assay

2476

22067

1.20

10.66

7.4

7.9

inr

1.2

0.88

740

6218

(3018010) Neutrophils/100 leukocytes in Blood

2979

27001

1.19

10.59

5.6

5.8

56.9

57.0

0.18

2737

25042

(3021589) Normoblasts [#/volume] in Blood

2775

25080

1.19

9.98

9.9

9.4

e9/l

0.0

0.07

2260

20354

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

726

5697

1.31

9.93

3.2

3.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3323

30510

1.18

9.89

5.6

5.9

umol/l

10.2

10.3

0.16

3119

28775

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6156

60139

1.44

9.86

11.2

10.8

u/l

23.8

23.6

0.30

5878

57894

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3024

27597

1.18

9.53

5.3

mmol/l

1.2

3.42

2654

24797

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2752

24924

1.18

9.49

3.0

2.8

ug/l

103.5

105.8

0.16

2498

22965

(3048689) Calprotectin [Mass/mass] in Stool

899

7296

1.27

9.44

2.1

2.0

ug/g

108.1

128.1

1.28

669

5592

(3022145) Colonoscopy Study observation

829

6667

1.28

9.37

1.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5757

55735

1.29

9.32

5.0

4.7

mmol/l

5.8

5.9

0.43

5139

50573

(40761511) CBC panel - Blood by Automated count

6006

58502

1.35

9.15

13.8

13.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5466

52626

1.24

9.08

5.9

5.7

mmol/mol

39.3

39.5

0.44

4949

48341

(3035941) MCH [Entitic mass]

6315

62107

1.58

8.72

21.7

20.9

30.0

30.2

8.48

6208

61181

(3024731) MCV [Entitic volume]

6315

62108

1.58

8.70

21.7

21.0

90.8

91.2

9.88

6208

61185

(3010813) Leukocytes [#/volume] in Blood

6316

62125

1.58

8.64

21.9

21.1

e9/l

6.5

6.6

0.40

6135

60274

(3026361) Erythrocytes [#/volume] in Blood

6315

62116

1.57

8.60

21.8

21.0

e12/l

4.4

4.37

6132

60277

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

188

2910

0.64

8.57

1.4

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1264

10767

1.22

8.45

1.3

u/ml

11.6

13.5

0.40

430

4151

(3000963) Hemoglobin [Mass/volume] in Blood

6315

62128

1.57

8.44

21.9

21.1

g/l

131.7

131.6

0.19

6209

61219

(3007461) Platelets [#/volume] in Blood

6311

62086

1.56

8.37

21.8

21.0

e9/l

265.1

262.4

2.69

6156

60430

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3301

30527

1.17

8.35

6.0

mmol/l

1.2

3.53

2719

25630

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

381

2799

1.38

8.10

3.7

3.3

mmol/l

2.2

2.1

0.06

295

2167

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1590

13889

1.19

8.07

2.2

—

(3035350) Ketones [Presence] in Urine by Test strip

3090

28496

1.16

7.95

4.1

4.0

estimate

0.0

0.69

645

5036

(1761868) Lipid panel - Serum or Plasma

2081

18626

1.17

7.87

3.0

2.9

—

(3021601) Nitrite [Presence] in Urine by Test strip

3114

28772

1.16

7.72

5.6

5.4

estimate

0.0

1.34

645

5046

(3009261) Glucose [Presence] in Urine by Test strip

3137

29040

1.15

7.48

4.2

4.1

estimate

0.0

2.04

648

5110

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1537

13476

1.18

7.38

1.3

u/ml

1.5

1.6

0.21

350

3546

(3045414) Leukocytes [Presence] in Urine

374

2783

1.36

7.36

2.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

129

772

1.68

7.26

2.0

2.1

mg/l

24.3

26.6

0.19

203

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

262

1846

1.44

7.11

3.8

3.6

mmol/l

25.3

25.2

0.18

244

1682

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

415

3161

1.33

7.02

1.8

1.7

—

(3009343) pH of Capillary blood

387

2920

1.35

6.98

3.8

3.4

7.4

0.04

405

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

391

2955

1.34

6.98

3.8

3.4

kpa

5.2

0.10

365

2727

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5537

53672

1.21

6.93

4.2

4.0

mmol/l

1.3

5.89

4906

48509

(3022313) Gas panel - Capillary blood

291

2101

1.40

6.90

3.6

3.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1779

15872

1.17

6.81

1.6

mmol/l

1.4

1.3

0.90

1436

13201

(3015377) Calcium [Moles/volume] in Serum or Plasma

2373

21646

1.15

6.71

3.2

3.4

mmol/l

2.4

0.04

1988

18690

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

461

3589

1.31

6.69

1.8

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

308

2264

1.38

6.58

1.7

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1299

11335

1.18

6.50

1.4

1.5

g/l

2.2

2.3

0.84

700

6497

(3013115) Eosinophils [#/volume] in Blood

3177

29622

1.14

6.43

5.8

5.9

e9/l

0.2

0.60

2756

25823

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5765

56185

1.23

6.39

4.7

4.5

mmol/l

4.9

0.66

5193

51544

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5723

55746

1.22

6.30

4.8

4.4

mmol/l

1.6

0.76

5111

50862

(3006315) Basophils [#/volume] in Blood

3077

28660

1.14

6.26

5.6

5.8

e9/l

0.0

0.34

2630

24537

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

149

965

1.56

6.15

1.3

nmol/l

0.6

2.3

0.74

144

930

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

170

2.36

6.03

1.1

105.1

93.6

1.40

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5869

57359

1.24

6.00

5.3

5.0

mmol/l

2.9

2.8

0.17

5265

52369

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1821

16415

1.15

5.92

2.7

2.8

ng/l

1134.6

1180.7

0.20

1498

14054

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1291

11339

1.17

5.92

1.3

iu/ml

29.8

37.0

0.73

377

3714

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

430

3374

1.29

5.91

2.6

2.5

—

(3001604) Monocytes [#/volume] in Blood

3056

28520

1.13

5.90

5.6

5.8

e9/l

0.6

1.76

2614

24442

(3019198) Lymphocytes [#/volume] in Blood

3129

29258

1.13

5.83

5.7

5.8

e9/l

1.9

0.50

2740

25556

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

142

922

1.55

5.82

1.5

1.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

3468

32666

1.13

5.69

4.1

4.2

mmol/l

6.5

6.6

1.27

3273

30453

(3026782) Osmolality of Urine

1221

10713

1.17

5.65

2.6

2.7

mosm/kgh2o

501.3

503.7

0.15

1015

9003

(3045424) Erythrocytes [Presence] in Urine

152

1012

1.51

5.58

1.7

1.6

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

131

844

1.56

5.58

1.2

nmol/l

—

(3018095) Leukocytes [#/volume] in Urine

2179

19950

1.14

5.57

3.7

3.6

e6/l

101.9

111.9

0.30

1482

13504

(3037121) Protein [Mass/volume] in Urine

251

1837

1.38

5.56

2.2

2.8

g/l

0.3

0.27

611

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

177

2.27

5.53

1.1

96.7

89.3

0.98

(3013139) Helicobacter pylori Ag [Presence] in Stool

544

4446

1.24

5.35

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1462

13058

1.15

5.32

1.6

1.7

mg/l

1.1

0.01

1076

10004

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

145

969

1.51

5.25

1.3

nmol/l

0.5

0.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

533

4361

1.24

5.19

3.2

pmol/l

4.4

0.02

478

3822

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2914

27270

1.12

5.09

2.3

nmol/l

81.0

80.1

1.02

2525

24363

(3023323) Follitropin [Units/volume] in Serum or Plasma

383

3032

1.28

4.95

1.3

iu/l

33.5

35.8

0.66

334

2652

(4146454)

570

1.64

4.91

2.6

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1929

17639

1.13

4.89

2.0

2.1

u/l

135.8

169.4

2.27

1772

16396

(3002582) Erythrocytes [#/volume] in Urine

1816

16547

1.14

4.87

3.2

3.1

e6/l

38.6

62.8

1.55

1356

12334

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2655

24767

1.12

4.81

2.1

2.0

pmol/l

104.1

99.1

4.21

1172

11579

(36304419) Bacteria [Presence] in Urine

1660

15050

1.14

4.80

3.1

3.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

231

1712

1.36

4.79

1.3

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

175

1238

1.43

4.77

1.9

1.8

u/l

297.8

3844.6

5.10

462

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1577

14289

1.14

4.57

2.3

mg/l

3.1

3.0

0.22

1297

12244

(3022948) Iron [Moles/volume] in Serum or Plasma

989

8674

1.17

4.55

2.3

umol/l

13.0

12.6

0.91

897

7958

(3026493) Urate [Moles/volume] in Serum or Plasma

1536

13898

1.14

4.55

2.3

umol/l

5961.8

4463.8

0.63

1281

11813

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

132

897

1.48

4.47

1.3

1.2

—

(3017732) Neutrophils [#/volume] in Blood

494

4085

1.23

4.39

2.7

2.9

e9/l

3.9

4.0

0.41

360

3105

(3014271) Vancomycin [Susceptibility]

274

1.87

4.30

3.0

—

(3037522) Nuclear Ab [Titer] in Serum

959

8430

1.16

4.28

1.4

titre

532.1

592.2

0.54

215

1958

(40761535) Cells panel - Urine sediment

395

4819

0.81

4.07

3.1

3.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

261

2025

1.30

4.01

1.8

1.7

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

841

7361

1.16

3.97

2.4

21.6

21.3

0.20

723

6214

(3000850) Epithelial cells [#/volume] in Urine

1281

11562

1.13

3.89

2.7

2.5

e6/l

7.7

7.6

0.09

1090

10000

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.34

3.75

1.2

1.1

—

(3022621) pH of Urine by Test strip

478

4008

1.21

3.73

3.0

3.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2312

21635

1.11

3.68

4.5

4.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1244

11262

1.13

3.58

1.8

1.7

nmol/l

1156.3

1194.7

0.69

861

8414

(3004789) Transferrin [Mass/volume] in Serum or Plasma

892

7905

1.15

3.55

2.3

g/l

2.4

0.36

811

7258

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

105

2.29

3.51

1.0

1.1

100.3

78.8

—

(3026008) Bacteria identified in Urine by Culture

2250

21073

1.10

3.47

3.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

110

764

1.45

3.43

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

1669

15414

1.11

3.37

3.1

3.0

e6/l

0.3

0.4

1.61

1233

11363

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

158

1172

1.36

3.37

2.8

3.6

59.1

57.6

0.78

158

1172

(36660697) Celiac disease serology panel - Serum

568

4884

1.18

3.37

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

110

767

1.44

3.36

1.4

—

(3033658) Prothrombin time (PT) actual/Normal

1575

14503

1.11

3.36

3.6

95.6

94.2

1.37

1533

14083

(3024561) Albumin [Mass/volume] in Serum or Plasma

2718

25719

1.10

3.36

4.0

4.3

g/l

35.8

35.5

2.59

2503

23732

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.71

3.35

1.3

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

116

1622

0.71

3.34

3.8

4.0

mmol/l

3.9

3.8

1.20

107

1536

(3021387) Prolactin [Units/volume] in Serum or Plasma

171

1287

1.34

3.32

1.8

1.6

mu/l

312.9

327.0

0.37

152

1142

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

108

2.23

3.31

1.0

1.1

74.8

72.9

—

(3020891) Body temperature

162

2144

0.75

3.28

4.3

4.5

—

(3015183) Erythrocyte sedimentation rate

233

1.81

3.28

1.1

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1507

13866

1.11

3.25

1.6

1.5

nmol/l

21.7

0.01

1209

11696

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1048

9448

1.13

3.22

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

109

766

1.43

3.21

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

109

767

1.43

3.19

1.3

1.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

537

4618

1.18

3.19

4.2

4.0

0.1

0.45

137

1197

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

410

4857

0.83

3.17

2.6

2.7

ng/l

129.8

174.9

3.16

381

4440

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

111

786

1.42

3.15

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

513

4402

1.18

3.14

1.2

iu/ml

139.0

154.4

0.36

178

1702

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.63

3.13

1.1

1.7

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

262

3235

0.80

3.08

5.8

6.6

mmol/l

24.7

24.9

0.38

246

3010

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

744

6580

1.15

3.07

2.5

2.4

umol/l

5.8

7.6

3.06

644

5588

(3040151) Glucose [Moles/volume] in Capillary blood

543

1.50

3.05

3.3

4.1

mmol/l

7.2

0.03

446

(3002179) Metamyelocytes/100 leukocytes in Blood

512

4404

1.18

3.05

4.0

3.9

0.7

0.6

0.10

111

933

(3024522) Salmonella sp identified in Specimen by Organism specific culture

109

777

1.41

2.99

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1407

12954

1.11

2.98

1.7

pmol/l

20108179.8

34808189.8

0.58

1114

10558

(3005322) IgE [Units/volume] in Serum or Plasma

426

3617

1.19

2.96

1.3

u/ml

122.3

169.1

2.13

395

3303

(3006270) Folate [Moles/volume] in Blood

515

1.50

2.95

1.2

1.1

nmol/l

383.8

360.1

0.45

437

(40768441) Liver Pathology biopsy report

447

1.53

2.83

1.4

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

187

1462

1.29

2.82

1.3

u/ml

50.4

48.4

0.05

172

(40768443) Skin Pathology biopsy report

335

2798

1.21

2.80

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

221

1766

1.26

2.79

1.7

1.5

—

(4094501)

180

1403

1.29

2.78

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

109

790

1.39

2.75

1.3

1.4

nmol/l

0.6

0.3

1.31

552

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

159

1.89

2.74

1.8

3.5

ng/l

57.8

181.9

1.22

(4035726)

653

5771

1.15

2.74

1.4

—

(3019060) Gas panel - Arterial blood

280

3384

0.82

2.72

3.9

4.5

—

(4034850)

150

1944

0.77

2.68

9.3

9.6

—

(3021788) Differential panel - Synovial fluid

139

1056

1.32

2.61

1.4

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

200

1594

1.26

2.61

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

253

2076

1.23

2.55

1.8

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

227

0.40

2.53

10.0

10.3

nmol/l

1223.4

878.4

—

218

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

581

5125

1.15

2.52

3.2

3.1

ng/l

81.9

81.7

0.02

480

4308

(3013650) Neutrophils [#/volume] in Blood by Automated count

3484

33584

1.08

2.51

8.5

9.2

e9/l

4.0

0.09

3023

29265

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

184

1460

1.27

2.50

1.8

2.3

178.1

191.1

1.06

173

1379

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

750

6730

1.13

2.50

3.3

3.8

ug/l

23.9

25.4

0.05

580

5338

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3509

33839

1.08

2.49

2.8

—

(3014051) Protein [Presence] in Urine by Test strip

183

1453

1.27

2.48

2.3

2.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

180

1427

1.27

2.47

2.0

2.4

g/l

3.5

3.6

0.46

168

1351

(3009542) Hematocrit [Volume Fraction] of Blood

5146

50423

1.10

2.47

15.6

15.4

39.0

38.7

1.34

3556

35121

(3017181) Myelocytes/100 leukocytes in Blood

550

4842

1.15

2.46

4.2

4.0

1.1

0.9

0.33

144

1300

(3021901) Oxygen saturation in Capillary blood

111

824

1.35

2.46

3.5

2.8

—

(3025159) Blasts/100 leukocytes in Blood

499

4363

1.16

2.46

4.2

4.1

0.1

0.6

1.06

121

1020

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

953

8682

1.11

2.45

2.7

e6/l

4.5

0.01

485

4414

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

402

4653

0.85

2.42

2.2

2.6

ml/min/173m2

64.8

64.7

0.02

148

1921

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

272

2263

1.21

2.41

1.9

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

282

2358

1.20

2.38

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.21

2.37

1.2

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

153

1201

1.28

2.30

2.4

3.2

u/ml

569.9

605.5

0.03

142

1081

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

211

1721

1.23

2.29

1.8

iu/l

5.1

4.8

0.16

621

(3020682) Albumin/Creatinine [Ratio] in Urine

1801

16966

1.09

2.28

3.8

mg/mmol

5.4

8.0

2.34

965

9538

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

277

1.59

2.27

1.3

1.7

nmol/l

1.9

4.4

1.78

226

(3020650) Glucose [Presence] in Urine

128

1.88

2.20

1.6

1.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.34

2.18

2.0

1.1

—

(40768793) Breast Pathology biopsy report

268

2256

1.20

2.14

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

1618

15215

1.08

2.13

4.6

4.5

estimate

0.0

0.59

647

5052

(3042936) Bacteria identified in Isolate by Culture

824

7512

1.11

2.11

1.8

1.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

149

1181

1.27

2.10

4.3

3.5

mg/l

21.7

25.0

0.52

726

(3017143) Hepatitis C virus Ab [Presence] in Serum

577

5158

1.13

2.08

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

129

1006

1.29

2.08

1.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.50

2.05

2.1

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

293

1.54

2.05

4.2

3.4

mu/l

28.1

23.8

0.28

282

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

121

938

1.30

2.04

1.3

1.4

u/l

31.9

36.4

0.74

762

(3012516) Albumin [Mass/volume] in Urine

1711

16150

1.08

2.04

3.1

mg/l

610.1

483.7

0.35

916

8985

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

191

0.42

2.04

1.0

1.1

—

(3049717) Cytology report of Urine Cyto stain

180

1466

1.23

2.02

2.3

2.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

579

5189

1.13

2.01

3.7

3.6

mmol/l

1.2

0.08

491

4458

(1002224) Polysomnography panel

233

1950

1.20

2.00

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

680

1.34

1.99

1.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

320

1.50

1.97

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

311

2673

1.17

1.97

1.2

1.3

u/ml

1.4

1.3

0.02

250

(3019150) Specific gravity of Urine by Refractometry

1158

12432

0.92

1.97

4.6

kg/l

1.0

0.17

242

1862

(3036481) Cortisol [Moles/volume] in Serum or Plasma

615

5542

1.12

1.96

2.1

nmol/l

373.9

377.5

0.17

558

5055

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

181

1481

1.23

1.95

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

633

0.66

1.95

1.2

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

471

4178

1.14

1.94

2.6

2.9

g/l

10.2

10.3

0.12

411

3838

(3025941) Bacteria identified in Stool by Culture

382

3342

1.15

1.92

1.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

990

9155

1.10

1.91

2.7

3.0

mmol/l

0.8

0.28

895

8459

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

219

1.60

1.90

1.6

ug/l

0.4

0.10

144

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

323

1.49

1.90

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

1779

16861

1.08

1.89

3.0

mmol/l

6.5

6.3

0.95

1437

13999

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1092

0.75

1.88

1.3

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

149

1201

1.25

1.86

2.6

2.2

g/l

125.8

126.8

0.16

843

(3028626) Oxygen [Partial pressure] in Capillary blood

125

987

1.27

1.86

3.4

2.8

kpa

8.3

8.1

0.60

118

912

(40762814) Titanium [Mass/volume] in Blood

100

1.90

1.85

2.7

2.1

ug/l

3.2

3.9

0.43

(40767503) Oxygen content in Capillary blood by calculation

136

1086

1.26

1.84

2.8

2.5

15.6

16.0

0.52

540

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

608

5497

1.12

1.84

2.2

2.3

u/l

44.1

41.3

0.11

515

4633

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

230

1941

1.19

1.83

1.3

u/ml

56.1

40.2

0.23

136

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.12

1.81

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

360

1.45

1.80

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

239

1.55

1.78

2.4

2.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

102

790

1.30

1.78

1.2

1.3

pmol/l

342.7

324.6

0.15

609

(3000570) Elastase.pancreatic [Mass/mass] in Stool

224

1893

1.19

1.76

1.5

1.4

ug/g

286.3

281.1

0.16

128

1090

(44790048)

546

0.66

1.76

1.2

1.4

—

(44790047)

546

0.66

1.76

1.2

1.4

—

(44806118)

546

0.66

1.76

1.2

1.4

—

(44790049)

546

0.66

1.76

1.2

1.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1898

18083

1.07

1.73

3.2

3.1

u/l

31.9

33.4

0.51

1794

17071

(3044927) Protein electrophoresis panel - Urine

586

1.34

1.70

1.1

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

2.10

1.65

1.5

1.4

11.3

15.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

111

879

1.27

1.65

1.4

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

279

2420

1.16

1.63

1.7

2.0

u/l

39.5

39.9

0.09

234

2155

(3027945) Reticulocytes/100 erythrocytes in Blood

635

5799

1.11

1.62

2.6

2.4

1.8

0.44

540

5112

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

190

1597

1.20

1.62

1.1

u/ml

7.0

7.2

0.01

173

(3026250) Tacrolimus [Mass/volume] in Blood

158

1.65

1.61

30.8

32.8

ug/l

7.2

0.03

144

(3043238) Trisomy 21 risk [Likelihood] in Fetus

523

0.67

1.61

1.2

1.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

639

5841

1.10

1.60

3.4

4.1

u/l

243.7

249.0

0.41

585

5491

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.50

1.59

2.3

1.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1313

12383

1.08

1.59

4.5

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

141

1154

1.23

1.58

3.5

3.0

mmol/l

25.2

25.4

0.17

128

1014

(4133840)

107

1.78

1.54

1.2

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

4741

46574

1.07

1.53

17.6

17.2

13.7

13.8

0.72

4652

45599

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.97

1.53

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

375

3336

1.13

1.53

1.5

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

162

1350

1.21

1.53

1.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.27

1.53

2.5

4.3

—

(3027801) Oxygen [Partial pressure] in Arterial blood

539

5921

0.90

1.52

6.1

kpa

13.0

12.6

0.90

513

5635

(3050129) First trimester maternal screen panel - Serum or Plasma

714

0.73

1.52

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

703

1.28

1.51

1.5

—

(21494755) Public health laboratory ask at order entry panel

367

4118

0.88

1.51

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

722

1.28

1.50

1.6

52.4

53.5

0.10

421

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

540

5925

0.90

1.49

6.1

kpa

5.1

0.35

517

5644

(3020961) Endomysium IgA Ab [Titer] in Serum

314

2767

1.14

1.49

1.1

titre

200.6

185.5

—

(3003396) Base excess in Arterial blood by calculation

539

5914

0.90

1.49

6.1

mmol/l

1.1

1.3

0.79

425

4717

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

206

2403

0.85

1.48

1.4

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

208

1780

1.17

1.47

1.3

u/ml

14.7

7.1

0.34

307

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.50

1.45

1.4

2.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

498

0.68

1.45

1.2

1.4

—

(4211845)

327

1.41

1.44

3.9

3.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

692

1.28

1.42

1.2

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

148

1233

1.20

1.42

1.3

1.2

—

(3005033) Fetal Nuchal fold Thickness US

496

0.68

1.42

1.2

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

355

1.38

1.39

1.1

nmol/l

14.5

9.5

0.23

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

104

1.73

1.36

4.9

4.6

u/l

59.3

41.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

689

6375

1.09

1.36

1.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

183

2138

0.85

1.36

3.9

4.7

0.9

0.53

169

2009

(3017446) Testosterone [Moles/volume] in Serum or Plasma

281

1.43

1.35

1.4

1.3

nmol/l

0.7

1.1

3.80

220

(3047007) Chlamydophila sp Ab [Presence] in Serum

796

1.25

1.35

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

248

1.45

1.34

1.1

1.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

539

1.30

1.34

1.1

—

39.8

—

(4024509)

707

1.26

1.34

1.7

—

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

1.33

0.0

1.0

—

0.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

575

1.29

1.33

3.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

593

0.72

1.33

1.2

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

556

6050

0.91

1.32

1.6

1.7

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

136

1.62

1.32

2.6

2.9

mg/l

8.0

7.9

0.02

107

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

592

0.72

1.31

1.2

1.4

—

(4281824)

125

1034

1.21

1.31

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

591

0.73

1.30

1.2

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

591

0.73

1.30

1.2

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

185

2149

0.86

1.29

3.9

4.6

1.6

0.34

171

2017

(3018572) Chloride [Moles/volume] in Blood

1151

0.81

1.29

4.6

6.3

mmol/l

104.8

104.9

0.08

1036

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

284

1.41

1.29

1.4

1.5

u/l

12.9

12.2

0.31

270

(3036489) Thrombin time

227

1980

1.15

1.29

1.5

1.8

20.8

21.3

1.15

197

1712

(3039000) Anion gap in Blood

1150

0.81

1.28

4.6

6.3

mmol/l

10.7

11.0

0.33

1035

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

228

1990

1.15

1.28

1.7

1.9

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

173

1479

1.17

1.27

1.5

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.94

1.27

1.5

1.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.00

1.27

1.8

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

803

1.24

1.26

1.2

u/l

21.7

19.4

0.53

653

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

221

1928

1.15

1.26

1.4

1.7

mg/l

3.3

3.4

0.06

148

1390

(3011985) Renin [Units/volume] in Plasma

104

849

1.23

1.25

1.2

1.4

mu/l

33.7

53.7

1.76

762

(3019897) Erythrocyte distribution width [Ratio] by Automated count

661

1.26

1.25

2.8

3.1

13.3

0.21

650

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

167

1427

1.17

1.24

1.2

—

16.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

450

1.31

1.23

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

202

1754

1.16

1.23

1.3

u/ml

1.9

6.4

1.53

196

(3052851) Hemolysis interference index of Serum or Plasma

208

1811

1.15

1.22

2.8

3.0

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

444

4861

0.91

1.22

6.7

g/l

118.7

118.5

0.09

425

4678

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

143

1209

1.19

1.21

3.1

2.8

mg/l

1.6

1.5

0.71

129

1109

(3024980) IgG subclass 4 [Mass/volume] in Serum

106

871

1.22

1.21

1.4

1.5

g/l

0.6

0.11

633

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

348

1.35

1.20

1.6

1.4

umol/l

11.5

11.3

0.10

331

(3000330) Specific gravity of Urine by Test strip

337

3033

1.12

1.19

3.4

3.8

—

(3047181) Lactate [Moles/volume] in Blood

139

1638

0.85

1.18

4.1

5.5

mmol/l

1.4

1.3

1.19

120

1454

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

2.31

1.18

2.0

2.1

mg/l

4.2

3.3

—

(3044889) 12 lead EKG panel

4120

40440

1.05

1.18

3.8

3.7

—

(40758358) Immune stain study

2.11

1.18

1.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

515

1.28

1.18

1.6

1.5

41.1

36.9

0.36

289

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

578

1.27

1.17

1.1

1.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

157

1.53

1.17

2.2

2.9

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.93

1.16

1.4

1.0

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

199

1735

1.15

1.16

1.9

2.1

ug/l

186.5

590.4

2.38

178

1591

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

190

1.48

1.16

1.4

1.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

147

1253

1.18

1.15

3.3

3.2

nmol/l

0.8

0.40

110

979

(3037556) Urate [Mass/volume] in Serum or Plasma

142

1.55

1.14

1.1

1.3

—

(3045788) Cell count panel - Pleural fluid

426

0.70

1.13

1.5

1.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.85

1.13

1.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

798

1.22

1.12

1.2

1.3

—

(3000492) Spirometry study

547

5062

1.09

1.12

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

119

1.60

1.11

1.2

1.6

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

397

1.31

1.10

1.1

1.0

mg/l

297.7

300.4

0.11

349

(3032868) Hemoglobin electrophoresis panel in Blood

2.26

1.10

1.4

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

363

1.32

1.09

1.1

1.6

u/l

4.8

5.9

1.28

303

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.38

1.09

11.0

9.5

—

(4010399)

472

4346

1.09

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

362

3291

1.11

1.08

1.8

g/l

1.4

1.3

0.21

317

2971

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

128

1.56

1.08

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

479

0.73

1.08

1.5

1.4

e6/l

127505.3

54973.6

0.29

271

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

563

6055

0.92

1.06

1.6

1.7

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

608

6516

0.93

1.05

6.1

6.0

mmol/l

104.4

104.1

0.83

595

6384

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

228

1.41

1.05

1.5

1.7

—

(3043410) Blood group antigens tested for on Red Blood Cells

121

1.57

1.05

2.3

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

192

1685

1.14

1.05

1.6

iu/ml

0.1

9.4

0.51

363

(3001019) Free T4 and TSH panel - Serum or Plasma

332

3012

1.11

1.04

1.7

1.8

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

138

1.52

1.02

1.1

—

(3000012) Reticulocyte production index

324

1.33

1.02

1.7

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

541

0.76

1.01

1.4

e6/l

3305.5

3311.5

0.00

394

(3023368) Bacteria identified in Blood by Culture

1455

13975

1.05

0.99

3.9

4.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

655

1.22

0.99

1.1

iu/ml

62.5

17936.9

0.57

137

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

453

4184

1.09

0.99

2.4

au/ml

16.6

27.9

1.13

229

(3018418) pH of Serum or Plasma

1935

18718

1.05

0.99

4.0

3.8

7.4

0.27

380

3440

(3004588) Protein electrophoresis panel - Serum or Plasma

429

3953

1.09

0.99

2.3

—

(3004616) Nuclear Ab [Presence] in Serum

810

1.20

0.99

1.2

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

472

4368

1.09

0.99

2.6

2.5

e9/l

69.3

71.2

0.56

340

3260

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

449

1.27

0.99

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

248

0.64

0.97

3.7

3.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.95

0.97

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.96

0.0

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.77

0.94

2.3

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

225

1.38

0.94

1.4

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

225

1.38

0.94

1.4

1.7

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

651

1.22

0.93

2.1

2.0

32.6

32.3

0.25

643

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

339

3102

1.10

0.93

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

600

0.78

0.92

1.5

1.4

g/l

33.8

32.8

0.20

549

(4212803)

1.73

0.92

1.2

1.0

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

445

1.26

0.92

3.6

3.1

nmol/l

169.8

138.2

0.19

438

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

269

1.34

0.92

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

269

1.34

0.92

1.3

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

156

1778

0.87

0.92

4.4

3.7

u/ml

81.9

37.0

0.71

148

1724

(3029075) Extractable nuclear Ab panel - Serum

167

1.44

0.91

1.2

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

287

1.33

0.91

1.5

1.0

3.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

672

1.21

0.90

1.1

g/l

1.5

0.08

593

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

429

0.74

0.90

1.5

1.7

—

(3051101) Glucose [Moles/volume] in Cord blood

102

0.49

0.89

1.8

6.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

103

876

1.18

0.88

1.3

1.2

—

(3003129) Base excess in Capillary blood by calculation

127

1.50

0.88

2.2

1.9

mmol/l

1.9

1.4

0.15

116

(3017569) Oxygen content in Arterial blood

228

1.36

0.88

2.1

2.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1246

11961

1.05

0.88

2.7

2.9

mmol/l

2.5

0.58

1093

10456

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1043

0.84

0.87

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1161

0.85

0.86

1.2

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

290

1.31

0.86

1.4

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

290

1.31

0.86

1.4

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

290

1.31

0.86

1.4

1.6

—

(3006462) Nitrate [Presence] in Urine

308

1.30

0.85

4.1

3.8

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.94

0.84

1.0

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

250

0.68

0.83

1.7

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

250

0.68

0.83

1.7

1.6

—

(4027681)

283

1.31

0.83

1.3

1.2

—

(3016018) Differential panel - Cerebral spinal fluid

579

1.21

0.82

1.2

1.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

356

3287

1.09

0.82

1.6

1.7

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

261

0.69

0.82

1.5

2.7

45.8

42.0

—

(3010375) cycloSPORINE [Mass/volume] in Blood

197

1.37

0.81

25.5

26.6

ug/l

108.8

102.0

0.29

163

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

690

1.19

0.81

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

166

1476

1.13

0.80

1.2

1.3

u/ml

2.8

5.7

—

115

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

329

1.28

0.80

1.8

2.6

e6/l

629.5

761.9

0.82

150

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

122

1.48

0.80

1.9

2.4

mmol/l

7.5

7.0

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

101

868

1.17

0.79

1.1

au/ml

14.8

16.9

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.79

0.0

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

414

4442

0.93

0.79

1.9

2.3

ug/l

6.7

5.7

0.36

327

3773

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.67

0.78

2.4

2.0

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

845

8057

1.06

0.78

1.9

2.0

29.4

0.07

816

7813

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.78

0.0

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

758

1.18

0.78

1.3

1.2

u/l

40.8

34.4

0.19

660

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.59

0.78

1.2

1.4

—

(3000494) Fungus identified in Specimen by Culture

712

6759

1.06

0.77

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

340

1.27

0.77

1.8

2.3

e6/l

557.2

497.9

0.28

282

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

412

1.24

0.76

1.3

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

797

1.17

0.76

1.4

1.3

u/ml

158.3

120.9

0.38

189

(3000093) Morphology [Interpretation] in Blood Narrative

449

1.23

0.75

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

112

975

1.15

0.75

1.2

—

(3016502) Oxygen saturation in Arterial blood

486

5173

0.93

0.75

6.3

6.5

95.4

95.9

0.67

463

4972

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

169

1512

1.12

0.75

1.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

256

2342

1.10

0.75

1.6

u/ml

22.5

12.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

174

1560

1.12

0.75

1.7

2.0

mg/l

11.1

11.4

0.24

151

1445

(3036525) Urea [Moles/time] in 24 hour Urine

2.08

0.74

2.2

2.8

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

200

1809

1.11

0.73

3.2

3.3

mg/l

59.1

77.8

0.21

157

1468

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.84

0.73

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

150

1.40

0.73

1.0

u/ml

1.0

1.2

0.08

(3011288) Drugs identified in Urine by Screen method

662

1.18

0.72

1.4

2.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

194

1754

1.11

0.72

3.2

ratio

1.5

0.08

135

(3042111) Morphology [Interpretation] in Bone marrow Narrative

100

867

1.16

0.72

1.7

1.5

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

362

1.24

0.71

1.1

mg/l

282.9

237.0

0.71

321

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

480

1.21

0.71

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

480

1.21

0.71

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

291

1.27

0.70

1.4

1.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

417

1.22

0.70

1.4

1.2

titre

252.5

153.5

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

481

1.21

0.70

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

706

0.83

0.69

1.2

mmol/l

7.1

7.6

0.57

517

(3036071) Salmonella sp Ab [Titer] in Serum

152

1.38

0.69

1.2

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.85

0.68

1.2

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

144

1.39

0.67

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

144

1.39

0.67

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

144

1.39

0.67

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

144

1.39

0.67

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

120

0.58

0.67

1.0

1.1

—

(3047189) Immunofixation for 24 hour Urine

238

0.71

0.67

1.7

1.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

232

2128

1.09

0.66

3.1

u/ml

88.9

1044.9

2.14

194

1782

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

199

1812

1.10

0.66

3.2

3.3

mg/l

24.9

41.2

3.23

157

1470

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

176

1942

0.90

0.66

1.8

1.9

ug/l

0.8

2.1

4.44

147

1710

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

0.53

0.66

1.4

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

223

1.30

0.66

5.0

4.1

—

(3033799) Differential panel - Peritoneal fluid

162

1.36

0.66

1.5

1.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

828

1.15

0.65

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

406

3812

1.07

0.65

1.3

au/ml

63.2

46.0

—

169

(3019977) pH of Arterial blood

268

1.27

0.65

2.5

2.9

7.4

0.18

(3000475) Leukocytes [#/volume] in Synovial fluid

156

1405

1.11

0.65

1.6

e6/l

11547.7

11448.0

0.01

113

1006

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

449

1.20

0.65

1.7

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

470

0.81

0.63

1.9

mg/l

2.7

3.6

1.20

449

(4062490)

561

1.18

0.63

1.2

1.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

200

1829

1.10

0.62

1.5

1.8

g/l

0.2

0.06

189

1727

(3042733) HLA Ab [Presence] in Serum

104

1.44

0.62

3.6

5.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

479

1.19

0.62

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

479

1.19

0.62

1.2

—

(3008295) Osmolality of Serum or Plasma

621

0.84

0.62

1.3

1.4

mosm/kgh2o

277.5

274.7

0.37

465

(3020491) Glucose [Moles/volume] in Blood

388

1.21

0.61

4.0

1.6

mmol/l

6.4

6.9

1.39

267

(3004809) Band form neutrophils/100 leukocytes in Blood

102

899

1.14

0.61

2.9

3.2

1.3

0.02

700

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

480

1.19

0.61

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

523

4964

1.06

0.61

1.5

1.6

1.4

0.01

441

4324

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

244

1.27

0.61

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

511

0.82

0.60

1.5

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

781

0.86

0.60

1.2

u/l

58.5

59.7

0.08

520

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

769

1.15

0.60

1.1

u/ml

4.6

3.6

0.15

330

(46235355) HIV 1 and 2 tests - Meaningful Use set

712

6817

1.05

0.60

1.7

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1371

14114

0.96

0.60

3.7

4.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

995

9602

1.04

0.59

2.6

e6/l

1.4

1.7

0.53

530

5292

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

273

1.25

0.58

1.4

1.8

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

410

1.20

0.57

1.3

1.2

—

(3003694) ABO and Rh group [Type] in Blood

1359

13978

0.96

0.57

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

104

924

1.13

0.56

1.4

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

167

1.32

0.56

1.1

1.3

33.7

21.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

115

1.39

0.56

1.1

—

(3036603) Volume of Urine

420

1.19

0.56

1.5

1715.9

1994.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

141

1.35

0.56

1.1

—

(40768806) Pleura Pathology biopsy report

484

0.83

0.56

1.7

1.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.58

0.56

1.2

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

308

0.78

0.56

1.2

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

559

1.16

0.56

3.0

3.2

51.0

58.1

1.42

365

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.62

0.55

1.0

—

(3017509) Phencyclidine [Presence] in Urine

1.62

0.55

1.0

1.3

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.62

0.55

1.3

1.6

umol/l

0.7

0.9

—

(4306422)

766

1.14

0.55

1.1

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

412

1.19

0.55

1.3

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

123

0.65

0.54

1.3

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

204

1883

1.09

0.54

1.5

1.7

g/l

1.2

0.16

194

1779

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

294

1.23

0.54

1.1

u/ml

10.2

5.7

—

(40758292) HTLV I+II Ab panel - Serum

1.45

0.53

1.4

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.43

0.52

1.1

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.62

0.52

1.2

1.1

u/ml

62.3

54.8

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

378

1.19

0.52

1.2

mg/l

42.9

34.9

0.29

329

(3051651) Icteric interference index of Serum or Plasma

359

0.81

0.51

3.9

3.1

—

(3051611) Lipemic interference index of Serum or Plasma

667

1.14

0.51

3.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

640

0.86

0.51

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

565

1.15

0.50

1.2

1.4

g/l

6.1

6.6

0.86

380

(3024139) IgG subclass 3 [Mass/volume] in Serum

565

1.15

0.50

1.2

1.4

g/l

0.4

0.01

382

(3028192) IgG subclass 2 [Mass/volume] in Serum

565

1.15

0.50

1.2

1.4

g/l

2.6

2.8

0.27

382

(44813793)

444

1.17

0.50

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

144

1.32

0.50

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

488

0.84

0.50

3.8

3.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

162

1.30

0.50

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.49

0.49

1.9

2.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

101

1.39

0.49

1.1

—

(3008898) HLA-B27 [Presence]

204

1894

1.08

0.49

1.1

—

(3024932) HLA-DR beta [Type]

119

1.35

0.48

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

235

1.24

0.48

1.2

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

823

1.12

0.47

1.3

1.2

u/ml

284.3

286.9

0.03

503

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

168

1550

1.09

0.47

1.8

2.0

94.9

94.7

0.04

154

1425

(3000991) Gas panel - Venous blood

403

4235

0.95

0.47

7.1

6.7

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

137

1.31

0.47

1.1

umol/24h

1.7

0.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

259

2757

0.94

0.47

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

485

1.16

0.46

1.4

1.5

u/ml

20.1

21.2

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

232

2478

0.93

0.46

2.8

3.0

mmol/l

25.7

25.5

0.73

226

2412

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

430

1.16

0.46

1.3

u/ml

1.5

1.0

0.24

194

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

117

0.68

0.45

1.5

1.6

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.61

0.45

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.61

0.45

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.61

0.45

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

138

1.31

0.45

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

246

1.22

0.45

2.0

2.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.59

0.45

2.2

2.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

103

1.36

0.45

1.3

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

283

1.20

0.44

1.0

u/ml

0.6

1.5

0.39

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

516

1.14

0.44

1.7

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.37

0.44

1.9

2.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.37

0.44

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

703

0.88

0.43

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

782

1.11

0.43

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.61

0.43

1.2

1.0

—

23.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

887

1.11

0.43

2.5

2.6

umol/l

33.7

33.4

0.03

748

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

151

0.73

0.42

1.2

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

118

1079

1.10

0.42

1.2

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

702

0.88

0.42

1.1

—

(3035880) pH of Pleural fluid

229

0.79

0.42

1.3

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

122

1.31

0.42

1.3

1.4

g/l

12.6

13.4

0.12

101

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

1.38

0.42

2.1

1.4

35.3

52.8

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

280

2649

1.06

0.41

7.7

7.4

mmol/l

24.5

24.6

0.18

258

2465

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

298

2825

1.06

0.41

1.5

1.4

—

(3022229) Phosphate [Moles/volume] in Urine

0.00

0.41

0.0

1.0

—

15.2

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.41

0.0

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

146

1351

1.08

0.41

3.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

161

0.74

0.41

1.1

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

627

6055

1.04

0.40

1.6

1.7

—

(3000060) B lymphocytes [#/volume] in Blood

114

1.32

0.40

1.2

2.1

e6/l

424.0

132.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

539

1.13

0.40

1.2

—

(3024471) HLA-A [Type]

123

1.30

0.40

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.47

0.40

7.4

4.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

194

0.77

0.40

1.2

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

436

1.15

0.40

2.0

1.7

umol/l

9.4

7.6

0.27

312

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

160

0.75

0.39

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.31

0.39

1.3

1.1

umol/24h

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.31

0.39

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

451

4329

1.04

0.39

1.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

127

1171

1.09

0.39

1.3

1.4

e6/l

51.2

31.4

0.27

104

899

(3022217) INR in Platelet poor plasma by Coagulation assay

685

7073

0.96

0.39

23.8

inr

1.3

0.52

102

990

(21494890) Protein electrophoresis panel - 24 hour Urine

549

0.87

0.39

1.7

2.1

—

(40758558) Short blood count panel - Blood

1546

15162

1.03

0.38

6.0

6.9

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

189

1773

1.07

0.38

2.1

g/l

37.9

37.6

0.22

153

1506

(3023410) Appearance of Cerebral spinal fluid

543

1.12

0.37

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

216

1.20

0.36

2.6

2.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

191

0.78

0.36

2.8

1.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

198

1.21

0.36

1.0

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

118

1276

0.92

0.36

3.4

2.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

142

1322

1.08

0.36

1.5

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

444

4274

1.04

0.35

1.4

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

517

1.12

0.35

1.5

1.4

e6/l

116404.6

119933.6

0.01

339

(3000285) Sodium [Moles/volume] in Blood

0.62

0.35

2.0

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

153

1.24

0.35

2.3

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

153

1.24

0.35

2.3

2.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

122

0.74

0.35

1.3

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

125

0.72

0.35

1.0

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

723

7438

0.97

0.35

5.7

6.8

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

244

0.82

0.34

1.2

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

222

2102

1.06

0.34

2.2

g/l

9.4

10.1

1.83

176

1741

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.37

0.34

5.6

11.0

—

(3002032) Base excess in Venous blood by calculation

448

4647

0.96

0.34

3.2

3.4

mmol/l

1.7

2.1

1.88

376

3863

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

319

0.85

0.34

1.0

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

283

1.17

0.34

1.4

2.6

u/ml

767.4

1339.5

1.12

278

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

358

1.15

0.34

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

486

4693

1.04

0.34

2.6

2.5

g/l

66.1

66.4

0.41

433

4215

(3044941) Cell count panel - Synovial fluid

911

1.09

0.34

1.5

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

203

1919

1.06

0.34

2.3

g/l

0.6

0.8

0.36

165

1635

(3014599) Egg white IgE Ab [Units/volume] in Serum

274

1.17

0.33

1.0

u/ml

1.8

0.7

0.30

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

145

1.24

0.33

1.4

70.3

61.8

0.47

121

(3011412) CD3 cells [#/volume] in Blood

510

1.12

0.33

2.1

2.2

e9/l

1.3

1.2

0.33

314

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

467

0.88

0.33

1.1

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

199

0.80

0.33

1.1

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

593

0.89

0.33

1.2

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

126

1174

1.07

0.32

1.4

e6/l

1989.2

1221.6

0.23

110

953

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

233

2450

0.95

0.32

2.4

2.7

1.1

1.2

0.51

233

2438

(3020393) Adenovirus Ag [Presence] in Stool

1.28

0.32

1.0

—

(3001729) Color of Synovial fluid

1.28

0.32

3.0

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

302

2892

1.05

0.32

1.5

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

101

1091

0.92

0.31

2.2

2.4

ug/min

99.8

63.7

0.19

613

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

464

0.88

0.31

1.7

1.5

u/l

2.8

6.0

1.56

216

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.32

0.30

1.1

—

(3018133) Calcium [Moles/volume] in Urine

0.72

0.30

2.3

1.6

mmol/l

2.2

2.7

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

558

0.90

0.30

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

296

1.15

0.30

1.2

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

235

2241

1.05

0.30

2.1

2.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

278

1.15

0.29

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

130

0.77

0.29

1.3

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

167

1579

1.06

0.29

1.3

1.2

titre

115.0

156.6

0.40

136

(3034988) Calcium [Moles/volume] in Capillary blood

108

0.74

0.29

1.4

1.9

mmol/l

1.2

—

103

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

288

1.15

0.29

1.2

1.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

230

2407

0.95

0.28

2.4

2.7

0.7

0.21

222

2308

(21494434) Karyotype in Bone marrow

439

0.89

0.28

1.3

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

129

0.77

0.28

1.3

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

481

0.89

0.28

1.0

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

126

1340

0.94

0.27

1.2

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

556

1.10

0.27

1.3

1.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

120

0.75

0.27

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

761

0.92

0.27

1.1

u/ml

0.7

1.0

0.33

309

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

301

3125

0.96

0.26

1.5

—

(40768446) Kidney Pathology biopsy report

159

1.20

0.26

1.9

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

234

2241

1.05

0.26

2.1

2.2

g/l

3.6

3.7

0.92

159

1589

(40762365) Oxygen content in Arterial blood by calculation

0.69

0.26

2.0

2.5

ml/dl

15.5

14.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

424

1.11

0.26

2.4

—

(44806071)

0.68

0.26

1.2

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

310

1.13

0.25

1.4

1.2

—

(3042631) Mycobacterium sp identified in Specimen

703

1.08

0.25

2.9

2.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

453

4663

0.97

0.25

3.2

3.4

kpa

5.8

0.50

442

4525

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

288

0.87

0.25

1.5

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

258

2683

0.96

0.25

8.2

8.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

882

0.93

0.25

1.4

1.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

188

1.17

0.25

1.8

2.1

e6/l

5602.4

3683.6

0.13

122

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

234

2245

1.04

0.25

2.1

2.2

g/l

7.5

7.6

0.21

166

1677

(3003458) Phosphate [Moles/volume] in Serum or Plasma

709

6935

1.03

0.25

4.6

mmol/l

1.0

0.26

652

6363

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

226

1.15

0.24

2.5

—

36.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.18

0.24

1.4

2.9

u/field

0.7

0.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

911

0.93

0.24

1.2

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.17

0.24

1.0

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

562

5483

1.03

0.24

2.2

2.1

g/l

0.2

1.07

530

5109

(3005011) Chlamydia sp Ab [Titer] in Serum

0.74

0.24

1.7

1.8

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

569

0.91

0.24

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

139

1464

0.95

0.23

1.2

1.3

miu/ml

198.8

222.4

0.38

687

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

124

1173

1.06

0.23

1.3

mmol/l

3.7

0.09

116

1105

(3020717) Zinc [Moles/volume] in Serum or Plasma

322

1.12

0.23

1.3

1.4

umol/l

37.3

25.5

1.05

306

(3024354) Oxygen [Partial pressure] in Venous blood

375

3864

0.97

0.23

2.6

2.9

kpa

4.8

4.5

1.44

362

3736

(3026726) Creatinine [Moles/volume] in Specimen

1.32

0.23

1.6

2.6

umol/l

619.2

674.7

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

1.32

0.23

3.4

1.3

0.6

0.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

911

1.07

0.23

2.0

1.7

nmol/l

0.9

0.8

0.94

761

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

220

2114

1.04

0.23

2.2

2.3

g/l

3.1

0.21

162

1626

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

175

1673

1.05

0.23

1.2

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

134

1.19

0.22

1.5

1.8

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

209

1.15

0.22

1.1

ng/l

96.2

247.6

—

(3034426) Prothrombin time (PT)

181

1.16

0.22

1.3

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

629

6156

1.02

0.22

1.6

1.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

442

4535

0.97

0.21

5.8

5.7

mmol/l

1.3

0.82

430

4394

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.2

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.1

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

0.00

0.21

0.0

1.3

—

0.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.21

0.0

4.2

—

2.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.21

0.0

1.0

—

3.7

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.0

—

2.3

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.21

0.0

1.3

—

3007.6

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

843

0.94

0.21

1.4

1.7

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

392

1.10

0.21

1.2

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

469

1.09

0.21

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

427

4163

1.03

0.20

1.7

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

191

1836

1.04

0.20

1.7

1.6

titre

113.3

318.8

—

(3025577) Chromium [Mass/volume] in Blood

335

1.11

0.20

2.3

2.0

ug/l

1.9

2.9

1.98

293

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

383

1.10

0.20

1.2

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

364

1.10

0.20

1.0

ng/l

370.3

352.9

0.12

251

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.20

0.0

1.1

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.20

0.0

1.1

—

0.0

—

(3022475) Manganese [Moles/volume] in Blood

1.25

0.20

1.3

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

221

1.13

0.20

1.2

1.1

iu/ml

—

3.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

115

0.78

0.20

2.4

1.8

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

898

1.06

0.19

1.3

1.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

894

8802

1.02

0.19

1.7

1.8

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

404

1.09

0.19

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

119

1248

0.95

0.19

1.7

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

405

0.91

0.18

1.1

iu/ml

5.5

10.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

784

1.06

0.18

1.0

1.1

—

(3037756) Immunofixation for Serum or Plasma

124

1185

1.05

0.18

1.7

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

425

0.92

0.18

1.6

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

367

1.09

0.18

1.0

ng/l

683.6

710.6

0.14

242

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

241

2337

1.03

0.17

3.6

mmol/l

24.3

24.5

0.60

222

2096

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1113

10990

1.02

0.17

3.4

3.6

ng/l

169.5

260.5

1.22

799

8368

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

494

1.07

0.17

2.8

—

(3020876) Protein [Mass/time] in 24 hour Urine

444

0.92

0.17

2.0

1.9

—

0.3

—

(3035933) Granulocytes/100 leukocytes in Blood

129

1.16

0.17

1.0

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

139

1336

1.04

0.16

1.3

mg/l

485.0

515.3

0.34

129

1277

(3003888) Timothy IgE Ab [Units/volume] in Serum

803

0.95

0.16

1.1

u/ml

1.7

3.1

1.36

379

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

546

0.93

0.16

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

781

0.95

0.16

1.3

1.2

u/ml

2.6

4.3

1.99

314

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

370

1.08

0.15

1.0

ng/l

45.1

46.9

0.07

252

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.79

0.15

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

293

1.09

0.15

1.2

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

322

1.09

0.15

1.2

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

122

1172

1.04

0.15

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

122

1172

1.04

0.15

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

163

1576

1.04

0.15

2.2

g/l

0.0

0.66

146

1421

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

140

0.86

0.15

1.2

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

182

0.88

0.15

1.9

1.8

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.13

0.15

1.1

1.9

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

751

1.05

0.15

1.1

126.0

122.7

0.41

666

(3030981) Hyaline casts [#/volume] in Urine by Automated count

265

2584

1.03

0.15

2.7

2.4

e6/l

0.3

0.00

256

2491

(3012501) Base excess in Blood by calculation

121

1164

1.04

0.14

3.5

mmol/l

2.9

2.7

0.29

841

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

420

1.07

0.14

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

502

0.94

0.14

1.5

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.80

0.14

2.3

2.1

—

(3006653) Thiamine [Moles/volume] in Blood

254

0.91

0.14

1.2

1.4

nmol/l

129.1

132.2

0.15

254

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

233

0.90

0.14

1.2

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

665

1.05

0.14

5.6

4.8

u/ml

217.2

104.4

0.60

193

(3016038) Potassium [Moles/volume] in Urine

429

0.93

0.14

1.1

mmol/l

32.3

33.6

0.14

356

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

191

0.89

0.13

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

558

1.06

0.13

1.1

u/ml

2.3

2.5

0.06

193

(3008116) Ketones [Moles/volume] in Urine by Test strip

100

0.80

0.13

1.3

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

115

1193

0.96

0.13

1.3

1.5

—

(3044007) Cell count panel - Peritoneal fluid

151

1.13

0.13

1.9

2.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

267

1.09

0.13

1.2

1.4

nmol/l

1.1

1.3

0.27

210

(3051593) INR in Capillary blood by Coagulation assay

252

0.91

0.12

15.2

11.6

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

142

1.13

0.12

1.4

1.9

mg/l

6.8

10.1

—

116

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

334

0.93

0.12

1.3

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

453

1.06

0.12

1.4

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

158

0.89

0.12

1.3

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

708

1.05

0.12

1.2

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

473

1.06

0.12

7.3

6.1

—

(3017704) Immunofixation for Urine

282

0.92

0.12

2.2

1.7

—

(3024869) Neuronal Ab [Presence] in Serum

1.16

0.11

1.1

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

366

1.07

0.11

1.5

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

170

1656

1.03

0.11

2.4

2.8

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

353

0.93

0.11

1.2

1.3

—

(3045142) Bone marrow Pathology biopsy report

582

1.05

0.11

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

157

0.89

0.11

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

661

1.04

0.11

2.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

198

0.91

0.10

2.2

2.1

umol/l

52.8

57.2

0.24

152

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

208

0.91

0.10

1.4

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

125

1.12

0.10

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

107

1103

0.97

0.10

2.9

3.1

mmol/l

7.1

7.6

1.28

107

1080

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

870

1.03

0.10

1.1

u/ml

0.6

1.1

0.91

320

(3014765) Yersinia sp identified in Stool by Organism specific culture

187

1830

1.02

0.09

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

320

1.06

0.09

1.3

2.1

u/field

2.4

2.5

0.02

216

(3004775) Volume in Urine collected for unspecified duration

371

0.94

0.09

1.8

2.3

593.8

649.0

0.41

260

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

176

0.91

0.09

1.1

1.5

mmol/l

10.2

8.4

—

107

(21494814) CD8 cells/100 lymphocytes in Specimen

227

0.92

0.09

2.6

1.9

—

(3025130) Human papilloma virus identified in Specimen

101

1040

0.97

0.09

1.6

1.7

—

(3028707) Methadone [Presence] in Urine by Screen method

468

1.05

0.09

1.3

2.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

134

0.90

0.08

1.2

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

165

1.09

0.08

1.8

e6/l

1443.2

25461.1

—

(3003181) Sodium [Moles/volume] in Urine

114

1169

0.97

0.08

1.3

1.4

mmol/l

58.7

61.7

0.43

929

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

549

1.04

0.07

1.1

85.2

95.5

3.01

517

(3027944) Amphetamines [Presence] in Urine

1016

0.97

0.07

1.3

1.6

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

176

1.08

0.07

1.2

1.4

—

129425.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

682

0.97

0.07

1.3

1.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

459

0.96

0.07

1.3

1.2

u/l

94.0

78.0

0.38

401

(40765096) Chromosome analysis panel by Banding

143

0.91

0.07

1.2

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

144

1469

0.98

0.07

4.3

4.8

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.03

0.07

11.4

7.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

409

4134

0.99

0.07

6.5

6.2

mmol/l

9.1

9.2

0.14

384

3938

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

489

0.96

0.07

1.1

1.0

u/ml

0.3

0.4

0.06

101

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.85

0.07

1.1

2.0

umol/l

15.3

17.5

—

(4015189)

157

1.08

0.07

2.6

2.5

—

(3000764) Benzodiazepines [Presence] in Urine

100

1024

0.98

0.07

1.3

1.6

—

(3011648) Oxygen content in Venous blood

407

0.96

0.06

2.4

2.0

10.3

10.7

0.26

407

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

132

0.91

0.06

1.2

1.0

—

(3041354) Potassium [Moles/volume] in Venous blood

670

1.03

0.06

2.2

mmol/l

4.0

0.42

665

(3035285) Chloride [Moles/volume] in Venous blood

670

1.03

0.06

2.2

mmol/l

105.9

105.4

0.40

665

(3022493) Free Hemoglobin [Mass/volume] in Plasma

183

0.93

0.06

1.0

4.7

mg/l

59.4

1236.0

—

124

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

158

1553

1.02

0.06

2.2

2.3

g/l

0.0

0.00

146

1416

(3028433) Virus identified in Specimen by Culture

197

1.07

0.06

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

111

0.90

0.06

1.0

1.3

—

(3028300) Cannabinoids [Presence] in Urine

101

1032

0.98

0.06

1.3

1.6

—

(3022689) Creatine [Moles/volume] in Urine

162

0.93

0.06

1.2

1.4

—

(3016750) Collection duration of Urine

276

1.05

0.06

1.5

2.3

min

464.5

502.2

0.95

209

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

172

0.93

0.06

2.2

1.5

ug/l

9.6

8.6

0.25

172

(3016650) Hepatitis A virus Ab [Presence] in Serum

819

0.98

0.05

1.1

—

(3010421) pH of Blood

139

1368

1.02

0.05

3.3

3.4

7.4

0.61

120

1138

(3009466) Valproate [Moles/volume] in Serum or Plasma

667

0.97

0.05

4.4

5.0

umol/l

342.6

371.6

0.84

574

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

163

1607

1.01

0.05

2.6

3.1

u/ml

0.3

0.4

1.24

947

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

222

0.95

0.05

1.1

miu/ml

1439.2

1541.8

0.19

222

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

226

2286

0.99

0.05

1.5

1.6

g/l

1.6

0.02

184

1950

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

394

0.96

0.05

1.3

1.5

—

(3024928) Oxygen saturation in Venous blood

102

1039

0.98

0.05

2.7

2.9

—

(3013727) Leukocytes other/100 leukocytes in Blood

169

1.07

0.05

2.9

3.3

56.7

51.5

0.45

161

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

179

1.06

0.05

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

466

1.03

0.04

1.4

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

466

1.03

0.04

1.4

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

466

1.03

0.04

1.4

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

201

0.95

0.04

3.3

2.9

umol/l

32.8

27.7

1.14

152

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

486

1.03

0.04

1.9

2.3

u/field

4.7

2.1

1.31

197

(42529406) Shigella sp [Presence] in Stool by Culture

186

1839

1.01

0.04

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

342

0.96

0.04

1.0

—

(1616796) Gas panel - Central venous blood

108

1097

0.98

0.04

4.0

3.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

103

1046

0.98

0.04

1.8

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

183

1811

1.01

0.03

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

784

0.98

0.03

1.3

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

331

0.97

0.03

1.1

ratio

1.0

1.1

0.14

125

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

240

0.96

0.03

1.4

1.7

umol/l

62.6

126.3

2.33

129

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

956

1.01

0.03

4.0

4.6

iu/ml

293.1

527.3

0.92

128

(1001926) Buprenorphine [Presence] in Urine by Screen method

783

0.98

0.03

1.3

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

608

1.02

0.03

5.2

6.5

mg/l

11.8

12.2

0.31

556

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

682

0.98

0.03

1.2

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

122

1.07

0.02

1.4

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

838

1.01

0.02

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

400

1.03

0.02

2.2

2.1

37.0

43.5

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

251

1.04

0.02

1.2

1.5

pmol/l

16.8

15.5

0.60

207

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

170

1686

1.01

0.02

2.2

g/l

0.0

0.66

152

1525

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

291

1.03

0.02

1.3

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

379

0.98

0.02

1.4

1.3

mmol/l

6.8

6.6

0.13

353

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

152

1508

1.01

0.02

1.9

1.8

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.08

0.02

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

539

0.98

0.02

1.2

u/ml

23.6

40.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

288

0.97

0.02

1.0

1.1

u/l

1.0

1.1

—

136

(4198724)

123

1.06

0.01

1.0

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

123

1.06

0.01

1.2

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

378

0.98

0.01

2.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

791

1.01

0.01

1.3

1.2

u/ml

4.1

3.4

0.08

250

(3023419) Bacteria identified in Sputum by Culture

648

0.99

0.01

2.7

2.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

688

0.99

0.01

1.1

u/ml

1.1

1.4

0.16

151

(3024263) Appearance of Synovial fluid

273

1.03

0.01

2.4

1.8

—

(3027008) Opiates [Presence] in Urine

102

1028

0.99

0.01

1.3

1.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

114

1.05

0.00

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

124

1233

1.01

0.00

1.3

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

184

1.03

0.00

1.3

g/l

39.9

38.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

214

1.03

0.00

1.2

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

188

1.01

0.00

3.5

2.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

278

1.01

0.00

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

598

1.00

0.00

1.1

u/ml

4.4

3.3

0.17

204

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

275

0.98

0.00

1.1

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

285

1.02

0.00

1.1

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

505

0.99

0.00

2.7

mg/l

30.9

33.0

0.04

344

(4268621)

545

0.99

0.00

2.3

2.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

585

1.01

0.00

1.3

1.2

—

(40768795) Lymph node Pathology biopsy report

685

1.01

0.00

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

116

1155

1.00

0.00

2.8

3.0

mmol/l

1.4

1.5

0.78

116

1129

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

134

0.97

0.00

1.1

—

(44806420)

156

1.03

0.00

2.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

117

1.03

0.00

1.3

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

127

1.02

0.00

1.2

1.4

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

236

1.02

0.00

1.0

u/ml

0.3

0.2

—

(3004451) EKG impression Narrative

254

0.98

0.00

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

386

1.01

0.00

1.4

1.2

mmol/l

13.4

11.6

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

394

0.99

0.00

2.0

1.9

14.8

14.6

0.04

158

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

237

1.01

0.00

1.0

1.1

—

(3016879) Cocaine [Presence] in Urine

934

1.00

0.00

1.3

1.6

—

(3013293) Extractable nuclear Ab [Presence] in Serum

131

0.99

0.00

1.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

311

1.00

0.00

1.2

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

451

1.00

0.00

2.5

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.88

0.00

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

1.2

—

(3036180) Methadone [Presence] in Urine

0.00

0.0

3.2

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

6.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.01

0.00

12.9

7.4

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(3042045) Bilirubin.total [Moles/volume] in Peritoneal fluid

0.00

0.0

1.0

—

18.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.98

0.00

1.5

2.6

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

7.7

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3048879) Bone marrow aspiration report

150

1.00

0.00

1.3

1.9

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.89

0.00

1.2

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.90

0.00

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

0.93

0.00

1.2

1.3

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

18.3

—

(3012441) Differential panel - Pleural fluid

450

1.00

0.00

1.5

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

3.5

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

230

1.00

0.00

1.8

2.2

ug/l

24.3

202.3

0.80

214

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.1

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.01

0.00

1.3

1.1

—

(3008717) Parietal cell Ab [Titer] in Serum

0.00

0.0

1.0

—

498.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.00

0.00

8.4

6.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

113.2

—

(3013762) Body weight Measured

0.00

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

0.87

0.00

1.3

1.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_LEIOMYOMA_ENDOMETRIOSIS – Benign leiomyoma with endometriosis

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Benign leiomyoma with endometriosis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints